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ABSTRACT 
Medical genetics and genetic technology have evolved rapidly during the past 
decades. Whole genome and exome sequencing are increasingly common in 
research settings, and they are likely to become more common in clinical 
settings as well. Efficient use of genomic information requires understanding 
of how lay people perceive hereditary risks and how they interpret genomic 
risk information. This study explored lay perspectives on risks of common 
diseases and secondary findings of genome sequencing.  
This study consisted of two quantitative and two qualitative sub-studies. 
Quantitative sub-study I (N=6258) examined whether family history of 
disease was related to perceived personal risk of diabetes, cardiovascular 
disease, cancer, and depression. Quantitative sub-study II (N=909) used 
structural equation modelling to examine relationships of perceived risks of 
diabetes and cardiovascular disease, health action self-efficacy and outcome 
beliefs, and risk indicators during a five-year follow-up. The study included 
people with a high or low to moderate diabetes risk status, who received 
biomarker feedback after baseline assessment. Participants of the quantitative 
sub-studies were from the FINRISK 2002 and 2007 health examination and 
survey studies, conducted by the Finnish National Institute for Health and 
Welfare.  
The qualitative inquiry (sub-studies III and IV) used a hypothetical 
scenario to examine lay perspectives on genetic secondary findings. 
Participants imagined themselves in a situation of receiving, via letter, a 
secondary finding predisposing to heritable cancer (Lynch syndrome or Li–
Fraumeni syndrome) or heart condition (long QT syndrome or familial 
hypercholesterolemia). Participants wrote down their immediate reactions 
(N=29) and discussed the topic later in focus groups (N=23). The transcribed 
data were analysed through inductive thematic analysis. Sub-study III 
explored concerns and needs related to secondary findings in general, whereas 
sub-study IV looked at how type of disease shapes these perspectives.  
Family history was related to perceived risk of common diseases 
independently of sociodemographics, health behaviour, body weight, and 
depressive symptoms. This association was weaker for depression compared 
to somatic diseases. (Sub-study I.) In the longitudinal setting, perceived risk 
or outcome beliefs did not predict changes in physical activity, body weight, or 
glucose tolerance. In contrast, those with higher baseline risk indicators 
tended to perceive higher disease risks after five years. Those with a high 
baseline self-efficacy increased their weekly physical activity. Results were 
similar among participants with a high risk for diabetes and those with a low 
or moderate risk, although those at high risk tended to underestimate their 
risk. (Sub-study II.) 
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Results of the qualitative inquiry showed that despite a positive attitude 
towards receiving secondary findings, people were worried whether relevant 
counselling and preventive care would be accessible for individuals and 
families. For the analysis concerning general perspectives on secondary 
findings, identified main themes were immediate shock, dealing with worry 
and heightened risk, fear of being left alone to deal with secondary findings, 
disclosing to family and support needs. Support needs included information, 
access to care, and empathetic communication. (Sub-study III.) Type of 
disease contributed to how these worries were emphasized. Main themes 
concerning types of diseases were familiarity, severity in terms of lived 
experience, cancer vs. heart disease, somatic vs. psychiatric disease, access 
to treatment, stigma, and responsibility. (Sub-study IV.) 
People tend to view their disease risks optimistically, but risk perceptions 
of common diseases reflect actual risk indicators. Perceived risk of disease or 
individualized biomarker feedback alone, however, are unlikely to result in 
sustained changes in daily health behaviour. Increasingly individualized risk 
communication practices need to also direct attention to counselling and 
supporting self-efficacy. Lay illness representations need to be taken into 
account in risk communication, as previous understandings of diseases shape 
how people process new risk information. When reporting genomic results, 
preventive treatment paths for individuals and families need to be planned 
and communicated appropriately.  
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TIIVISTELMÄ 
Lääketieteellinen genetiikka ja geeniteknologia ovat kehittyneet nopeasti 
viime vuosikymmeninä. Koko genomin tai eksomin laajuiset analyysit ovat 
yleistyneet geenitutkimuksessa ja ne yleistynevät tulevaisuudessa myös 
kliinisessä työssä. Geenitiedon paras mahdollinen hyödyntäminen edellyttää 
tietoa myös siitä, kuinka maallikot hahmottavat perinnöllisiä riskejä ja 
tulkitsevat genomitutkimuksista saatavaa riskitietoa. Tässä tutkimuksessa 
tutkittiin maallikoiden näkökulmia monitekijäisten kansantautien riskeihin ja 
genomitutkimusten sekundaarilöydöksiin. 
Tutkimus koostui kahdesta määrällisestä ja kahdesta laadullisesta 
osatutkimuksesta. Määrällinen osatutkimus I (N=6258) selvitti, onko 
sukuhistoria yhteydessä koettuun henkilökohtaiseen sairastumisriskiin 
diabeteksen, sydän- ja verisuonitautien, syövän ja masennuksen kohdalla. 
Määrällinen osatutkimus II (N=909) tutki rakenneyhtälömallinnuksen avulla 
yhteyksiä diabeteksen sekä sydän- ja verisuonitautien koetun 
sairastumisriskin, elintapamuutoksiin liittyvän pystyvyyskokemuksen ja 
tulosodotusten sekä riskitekijöiden välillä viiden vuoden seurannassa. Osalla 
tutkimuksen osallistujista oli korkea diabetesriski, osalla matala tai 
keskitasoa. Määrällisissä tutkimuksissa käytettiin Terveyden ja hyvinvoinnin 
laitoksen keräämiä FINRISKI 2002 ja 2007 kysely- ja 
terveystutkimusaineistoja.  
Laadullisessa osassa (osatutkimukset III ja IV) tutkittiin maallikoiden 
näkökulmia sekundaarilöydöksiin eläytymismenetelmän avulla. Osallistujat 
eläytyivät kuvitteelliseen tilanteeseen, jossa saivat kirjeellä tiedon 
sekundaarilöydöksestä, joka altistaa perinnölliselle syövälle (Lynch 
oireyhtymä tai Li–Fraumeni oireyhtymä) tai sydänsairaudelle (pitkä QT-aika 
-oireyhtymä tai familiaalinen hyperkolesterolemia). Osallistujat kirjoittivat 
ensireaktionsa (N=29) ja keskustelivat aiheesta myöhemmin fokusryhmissä 
(N=23). Litteroitu aineisto analysoitiin induktiivisen temaattisen analyysin 
menetelmällä. Osatutkimus III tarkasteli sekundaarilöydöksiin liittyviä huolia 
ja tarpeita yleisellä tasolla, ja osatutkimus IV selvitti, kuinka kyseessä olevan 
taudin luonne muovasi näitä näkökulmia. 
Sukuhistoria oli yhteydessä kansantautien koettuun riskiin riippumatta 
sosioekonomisista tekijöistä, elintavoista, kehon painosta tai 
masennusoireista. Masennuksen kohdalla yhteys oli heikompi kuin 
somaattisten sairauksien kohdalla. (Osatutkimus I). Pitkittäisasetelmassa 
koettu riski ja tulosodotukset eivät ennustaneet muutoksia liikunnassa, kehon 
painossa tai glukoosinsietokyvyssä. Päinvastoin lähtötilanteen kohonneet 
riskitekijät ennustivat korkeampia koettuja riskejä viiden vuoden päästä. Ne, 
joiden pystyvyyskokemus oli lähtötilanteessa korkea, lisäsivät liikuntaa viiden 
vuoden seurannan aikana. Tulokset olivat samanlaiset osallistujilla, joilla oli 
lähtötilanteessa korkea diabetesriski ja heillä, joiden riski oli matala tai 
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keskitasoa. Korkeassa riskissä olevat kuitenkin aliarvioivat riskinsä. 
(Osatutkimus II.) 
Laadullisen osan tulokset osoittivat, että huolimatta myönteisestä 
suhtautumisesta sekundaarilöydösten vastaanottamiseen, osallistujat olivat 
huolissaan aiheeseen liittyvän neuvonnan ja ennaltaehkäisevän hoidon 
saatavuudesta yksilöille ja perheille. Sekundaarilöydöksiin liittyviä yleisiä 
näkökulmia tarkastelevan analyysin keskeiset teemat olivat välitön shokki, 
huolen ja riskin käsittely, pelko yksin jäämisestä sekundaarilöydöksen 
kanssa, perheelle kertominen ja tuen tarpeet. Tuen tarpeisiin kuului tieto, 
hoitoon pääseminen ja empaattinen vuorovaikutus. (Osatutkimus III.) 
Sairauden luonne toi osansa siihen, kuinka näitä huolia painotettiin. 
Sairauden luonnetta koskevat keskeiset teemat olivat tuttuus, vakavuus 
elettynä kokemuksena, syöpä vs. sydänsairaus, somaattinen vs. 
psykiatrinen sairaus, hoitoon pääseminen, sosiaalinen leima ja vastuu. 
(Osatutkimus IV.) 
Ihmiset arvioivat riskejään optimistisesti, mutta kokemukset 
kansantautien riskeistä heijastelevat tosiasiallisia riskitekijöitä. Koettu riski 
tai terveystarkastuspalautteen saaminen ei kuitenkaan yksinään 
todennäköisesti johda pysyviin elintapamuutoksiin. Yhä yksilöllistetymmässä 
riskiviestinnässä tulee huomioida myös neuvonnan ja pystyvyyskokemusten 
merkitys. Maallikoiden käsitykset sairauksista on huomioitava 
riskiviestinnässä, sillä ne muovaavat uuden riskitiedon käsittelyä. Kun 
annetaan genomitutkimuksista saatavaa riskitietoa, ennalta ehkäisevät 
hoitopolut yksilöille ja perheille on suunniteltava ja selvitettävä riskitiedon 
saajalle asianmukaisesti. 
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 INTRODUCTION 
Risk communication is a common health promotion strategy. Risk factors of 
common chronic diseases are frequently discussed in the media, and also the 
healthcare informs patients about risks that may be related to their family 
history, lifestyle, or physiological measures. Common diseases like type 2 
diabetes, cardiovascular diseases (CVD), and cancers are usually 
multifactorial; their risk factors include health behaviour, environmental 
exposures, and genetic predisposition. Currently, there is a trend of 
personalized medicine, which hopes to provide more individualised risk 
information and treatment (Katsios & Roukos, 2010). An essential component 
of personalised medicine is taking into account individual genetic 
predispositions. Whole genome sequencing means mapping an individual’s 
entire DNA sequence at once, whereas whole exome sequencing maps the 
protein coding region of the genome. With these techniques it is possible to 
analyse individuals’ ancestry but also several types of health related 
information: polygenic risk scores for multifactorial diseases, 
pharmacogenetic variants that indicate individual harms or benefits of certain 
medications, carrier status of recessive diseases, and single variants that 
indicate high risks for diseases. Single variants that indicate disease risks are 
commonly called ‘secondary findings’ if they were not the initial target of the 
investigation.  A lot of expert discussion has been going on around how to 
handle various types of secondary findings.  
While clinical genetic testing for single gene disorders such as Huntington’s 
disease started in the late 1980s (Meissen et al., 1988), whole genome or 
exome sequencing has lately become more and more common in research 
settings and is likely to get integrated into clinical care in the near future. Costs 
of whole genome sequencing have decreased dramatically: sequencing the first 
human genome cost approximately 500–1000 millions of US dollars during a 
13-year project, whereas a few years ago (2016) whole genome sequencing 
generally cost less than 1000 US dollars (National Human Genome Research 
Institute, n.d.). Hence, it is getting more and more practical to use whole 
genome or exome sequencing instead of single genetic tests. To use genomic 
information for better health of individuals and populations, we also need to 
understand how lay people understand and use hereditary risk information. 
The European Society of Human Genetics states that public perspectives need 
to be taken into account when integrating genome sequencing into healthcare 
(van El et al., 2013).  
This study examines lay perspectives on hereditary risk information from 
two angles. First, the study uses nationally representative health examination 
and survey data to examine how health behaviour and family history of 
common diseases are related to personal disease risk perceptions. Second, the 
study uses a qualitative approach to explore lay people’s perspectives on 
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receiving secondary findings from genome sequencing. This study was 
conducted as part of a larger research project funded by the Academy of 
Finland (project number: 275033), which examined public understandings of 
genomics from various perspectives. The topic is timely as several countries, 
including Finland, have established national strategies for handling and taking 
use of genetic data (Ministry of Social Affairs and Health, 2015). The Finnish 
legislation around biobanks was recently updated (FINLEX ®, 2012). A 
special genome law is currently being prepared.  
 
1.1 GOALS OF PERSONALISED AND PREVENTIVE 
MEDICINE 
 
Personalised medicine aims to customize risk calculations and treatments 
individually (Katsios & Roukos, 2010). Recent decades’ advances in the field 
of genomics have particularly promoted this perspective. The trend of 
preventive medicine, however, has been prominent for a longer time. The idea 
is to allocate resources to preventing illness instead of only treating it, so that 
human suffering and treatment costs could be reduced. Research around risks 
for CVD, in particular, has a numerous decades long tradition in Finland 
(Puska, Vartiainen, Laatikainen, Jousilahti, & Paavola, 2009) and other 
countries (Dawber, Meadors, & Moore Jr, 1951). Between years 2000–2010 
there was a national diabetes prevention program in Finland (Saaristo et al., 
2007; Wikström et al., 2015). Despite efforts in risk communication to 
populations and individuals, chronic non-communicable diseases – including 
type 2 diabetes, CVD, and cancers – are extremely common worldwide 
(Lozano et al., 2012), and their prevalence is increasing. For example, 10.4% 
of adults worldwide are expected to have diabetes by 2040 (Ogurtsova et al., 
2017). Preventive methods include sustained changes in weight, diet, and 
physical activity (Lindström et al., 2006).  
In addition to chronic somatic diseases, depression and other mental 
disorders cause a significant disease burden. Depressive disorders are a 
leading cause of years lived with disability (Ferrari et al., 2013), and it is 
estimated that 4.4% of the global population are currently living with 
depression (WHO, 2017). In Finland, depression is a growing public health 
problem (Markkula et al., 2015). Adverse social circumstances are a major risk 
factor (Dunn et al., 2015). Similarly to common somatic diseases, genetic 
predisposition has a clear role in vulnerability to depression (Dunn et al., 2015; 
Sullivan, Neale, & Kendler, 2000), and health behaviours such as physical 
activity have preventive potential (Teychenne, Ball, & Salmon, 2008). 
However, risk communication practices for psychiatric disorders are 
considerably more cautious compared to somatic diseases. Reasons behind 
this include that their etiology is very complex, and that such risk information 
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is seen as potentially stigmatizing (Bunnik, Schermer, & Janssens, 2012; 
Kostick, Brannan, Pereira, & Lázaro-Muñoz, 2018). Many experts favour 
communicating psychiatric genetic risks but wish to avoid causing harmful 
distress to people who already have psychiatric problems (Kostick et al., 2018). 
Perspectives of preventive and personalised medicine tend to be combined. 
Individual disease risks are often at focus also without genetic testing: for 
example, there are easily accessible online risk assessment tools, which 
calculate individuals’ risks based on multiple risk factors (National Institute 
for Health and Welfare, 2018). One way, for health professionals and lay 
people alike, to assess individual disease risk is to look at family history. 
Family pedigrees are used in medical genetics when examining hereditary 
diseases that are caused by single genetic variants, but family history also 
predicts individual’s risk for multifactorial diseases (Guttmacher, Collins, & 
Carmona, 2004; Yoon et al., 2002). Particularly early onset indicates 
familiality of common diseases like CVD (Jousilahti, Puska, Vartiainen, 
Pekkanen, & Tuomilehto, 1996), diabetes (Almgren et al., 2011), cancer (Risch, 
2001), and depression (Levinson, 2006). Family history combines risk 
information from genetics and lifestyle, since health behaviour is often shared 
in families. For healthcare professionals, family history is easy to assess, since 
no genetic tests are needed. For lay people, family history is a meaningful way 
of evaluating genetic risk, since lay people tend to understand genetics in 
terms of traits and diseases that ’run in families’ (Condit, 2010b), instead of a 
more detailed understanding of how genes function.  
It is also known that individuals’ expectations affect how they interpret new 
risk information (Renner, 2004). Family history is likely to shape people’s 
expectations of genetic test results. For example, one study found that receipt 
of genetic test results concerning diabetes risk changed risk perceptions only 
among people who had diabetes in their family (Shiloh et al., 2015). This is 
why family history of disease needs to be taken into account when 
communicating genetic risks. Polygenic risk scores complement risk 
information indicated by family history, which continues to be an important 
tool for assessing risks for common multifactorial diseases (Aiyar et al., 2014).  
When using genome sequencing, for example to calculate polygenic risk 
scores, there is also the possibility to detect secondary findings. If a person’s 
genome or exome is sequenced for a specific reason, should also other health 
related variants be searched for and reported to the individual? Secondary 
findings usually refer to single variants that are known to implicate high risk 
for heritable diseases. Sometimes such findings are also called incidental 
findings. However, this term has been critized, since they are not, in fact, 
incidental or accidental, but finding them requires active analytical effort 
(Shkedi-Rafid, Dheensa, Crawford, Fenwick, & Lucassen, 2014). Often the 
term ‘secondary findings’ is preferred for this reason. 
Experts have intensely debated on the issue of secondary findings. The 
discussion has included several points of views: whether and what to report 
(Christenhusz, Devriendt, & Dierickx, 2013), how to deal with uncertainties of 
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genetic risk information (Newson, Leonard, Hall, & Gaff, 2016), how to obtain 
valid informed consent (Appelbaum et al., 2014; Berg, Khoury, & Evans, 2011; 
Bunnik et al., 2012; Mackley, Fletcher, Parker, Watkins, & Ormondroyd, 
2016), and how to balance between clinical and research ethics principles 
(Hallowell, Hall, Alberg, & Zimmern, 2015). Today, the overall consensus is 
that scientifically robust, analytically valid, clinically actionable findings 
should be reported to patients and research participants who have consented 
to receive them (Knoppers, Zawati, & Sénécal, 2015; Wolf, 2013). There are no 
guidelines for reporting variants of unknown significance (Solomon et al., 
2017), which could potentially evoke distress but would not lead to any 
medical interventions. As a response to what to report, the American College 
of Medical Genetics and Genomics (ACMG) has provided a list of 59 genes 
whose pathogenic variants should be reported to patients who consented to 
receive them in clinical settings (Kalia et al., 2016). This list includes genes 
that are related to ‘actionable diseases’, which means there are preventive 
methods available if the risk is known. The listed variants predispose to, for 
instance, certain cancers or cardiovascular conditions, whose preventive 
methods include surveillance, surgery, and medication.  
It has been pointed out that research settings and clinical practice are 
guided by, to some degree, different ethical principles (Hallowell et al., 2015). 
One important difference is that clinical practice is guided primarily by ethics 
of care, whereas participation in research is, in principle, supposed to be 
altruistic: the participant is not supposed to seek care or other benefits through 
participating research. This poses challenges, since genetic research and 
clinical practice tend to be embedded in practice, and it is not always clear, 
which ethical principles should be emphasized in different circumstances. 
Possibilities to provide counselling before consenting to receive secondary 
findings, for instance, are better in clinical settings where patients have face to 
face contact with healthcare professionals, compared to research settings 
where the same is not always possible. To handle secondary findings and other 
types of genomic information in ways that eventually promote health, we also 
need to understand how lay people understand and use such information. 
 
1.2 EXPERT AND LAY PERSPECTIVES ON GENOMICS 
 
Professionals and lay people tend to have somewhat different perspectives on 
genetics. Medical professionals may primarily think of the genome as a source 
of health information that can help diagnosis and risk assessment, but lay 
people interpret genetic information from the perspective of their whole life, 
identity, and social relations (Rehmann-Sutter & Mahr, 2016). Moreover, 
medical professionals have more detailed information on specific diseases and 
their treatment possibilities, whereas lay people make sense of different 
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diseases through more general dimensions (Leventhal, Meyer, & Nerenz, 
1980). Lay illness representations of diseases emphasize not only their 
symptoms and treatability, but also their consequences for one’s individual 
and social life as a whole. Hence, health professionals and lay people may see 
different kinds of potential to use and misuse genetic risk informaton of 
various types of diseases. Lay perspectives need to be taken into account when 
decisions are made about how genomic information is used in research and 
healthcare practices, in order to achieve acceptable practices that promote 
health. 
This thesis aims to shed light on the lay perspective on genetic risks, while 
acknowledging that the ‘professional’ and ‘lay’ divide is artificial and not 
mutually exclusive. Health professionals may be in the position of a patient or 
research participant similarly as anyone else; and also lay people have 
scientific knowledge about diseases and their prevention. Lay and professional 
understandings of diseases overlap in many ways (Damman & Timmermans, 
2012). In general, however, professionals have the possibility to take into 
account more detailed scientific knowledge about diseases and their 
heritability. Lay people may instead use, for instance, their personal 
experience of diseases. Furthermore, both lay and professional perspectives 
are contextualized in different social and cultural contexts. Structure of 
research and healthcare systems as well as cultural ideals (Press, Fishman, & 
Koenig, 2000) are likely to shape perspectives on how genomic information 
should be managed in practice. This study used quantitative and qualitative 
methods to explore lay perspectives on risks of common diseases and 
secondary findings of genome sequencing. Quantitative research is needed to 
gain overall understanding of how risk perceptions and health behaviours are 
related among the population, whereas qualitative research is needed to gain 
more nuanced understanding of how people make sense of new risk 
information. The context of the study is a Nordic society that has a tax-funded 
public healthcare and a highly educated population (Official Statistics of 
Finland, 2017).  
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 THEORETICAL BACKGROUND 
This study combines perspectives of health behaviour theories on risk 
perception and illness representations. Receipt of genetic secondary findings 
is conceptualized as a specific situation where receiving information on 
personal disease risk and disease characteristics may shift risk perceptions as 
well as illness representations. Risk information is not learned in a vacuum 
but within varied social contexts and individual life situations. People are not 
passive recipients of risk information but actively interpret it through their 
previous knowledge and beliefs (Gerrard, Gibbons, & Reis-Bergan, 1998). For 
example, interpretations of negative risk information may be self-defensive 
(Wright, 2010), and also unexpected risk information – regardless of whether 
positive or negative – is more likely to be considered unreliable and rejected 
(Renner, 2004). This study assumes that people’s previous beliefs about 
diseases and their personal risks are an important part of the context where 
new hereditary risk information is interpreted and acted upon. 
 
 
2.1 RISK PERCEPTION IN HEALTH BEHAVIOUR 
THEORIES 
Several health behaviour theories, for example the Health Belief Model 
(Becker, 1974) and the Health Action Process Approach (HAPA) (Schwarzer, 
2008) include perceived risk of a health outcome as one of the key components 
that preceed preventive action. There is some variation in how perceived risk 
is defined. Most commonly perceived risk is seen to consist of perceptions of 
likelihood and severity of a health outcome. Sometimes a distinction is also 
made between likelihood and susceptibility or vulnerability. In that case, 
likelihood simply refers to probability of an outcome, whereas susceptibility 
refers to personal vulnerability for it, irrespective of how common or likely the 
outcome is in general (Brewer et al., 2007). 
Risk communication is a common strategy to promote health behaviour. It 
has two aims: people are informed about their health risks to promote 
accuracy of risk perceptions and motivation to change health behaviour to 
reduce the risk (Weinstein & Nicolich, 1993). For example, people are told that 
obesity and lack of physical activity are risk factors for CVD and type 2 
diabetes, to encourage changes in physical activity and dietary behaviour. In 
practice, however, this is far from straightforward. People are not passive 
recipients of risk information but actively process the information by 
combining it with their previous knowledge and beliefs (Renner, 2004; 
Walter, Emery, Braithwaite, & Marteau, 2004), and successful health 
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behaviour change usually requires more than just risk perception (French, 
Cameron, Benton, Deaton, & Harvie, 2017). 
The relationship of risk indicators and perceived risk is assumed to be bi-
directional (Weinstein & Nicolich, 1993): risk behaviour is supposed to 
increase risk perceptions, which are expected to motivate preventive health 
behaviour changes, after which one is expected to re-adjust their risk 
perception. Risk perceptions may also be conditioned (Brewer et al., 2007). 
For example, a person who currently is not physically active may plan to 
increase their physical activity and thus perceive lower disease risks than their 
current activity level would indicate. Or, a person who currently has normal 
weight might believe that they will gain weight as they get older, and thus this 
person would perceive higher disease risks than their current body weight 
would indicate. For reasons such as these, interpreting research results on the 
associations of risk perception and health behaviour requires care and 
particularly needs to consider differences between cross-sectional and 
longitudinal study designs (Weinstein & Nicolich, 1993). When assessing 
whether risk perception predicts protective behaviour in longitudinal settings, 
it is important to take into account for the baseline level of the protective 
behaviour (Gerrard et al., 1998). 
In addition to actual risk factors, cognitive tendencies may contribute to 
risk perception. Most people are unrealistically optimistic about their future 
health (Weinstein & Klein, 1996). This optimistic bias is highlighted when 
people consider risks that they can control, such as their health behaviour 
(Klein & Helweg-Larsen, 2002). On the other hand, people who experience 
depressive symptoms might be more pessimistic (Alloy & Ahrens, 1987), which 
could increase their risk perceptions irrespective of their risk factors. The same 
bias could contribute to genetic fatalism, i.e. deterministic beliefs that there 
are no ways to prevent disease if the risk is inherited (Senior, Marteau, & 
Peters, 1999). 
Several health behaviour theories, including the Health Belief Model 
(Becker, 1974) and the HAPA, suggest that risk perception encourages health 
behaviour change, together with other social cognitive factors. The HAPA 
proposes a two-phase model of health behaviour change (Schwarzer, 2008). 
Intention for a health behaviour is formed in the motivational phase, which 
includes perceived risk, health action self-efficacy, and outcome beliefs as 
determinants of intention. Perceived risk includes perception of severity and 
likelihood of a health outcome, for example a chronic disease like type 2 
diabetes. Outcome beliefs refer to beliefs about efficiency of available 
preventive methods, such as physical activity or weight loss. In addition to 
physical outcomes, outcome beliefs may concern social outcomes, such as 
social approval, or self-evaluative outcomes, such as feelings of self-worth 
(Bandura, 2004). Health action self-efficacy refers to a person’s confidence 
that they are able to perform this preventive behaviour. Hence, a person who 
perceives they are at risk for diabetes and believes that physical activity and 
weight loss will efficiently prevent the illness, and believes they will manage 
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physical activity and weight loss, is expected to have an intention to be 
physically active and loose weight. According to HAPA, intention is translated 
into action in the second, volitional phase, through action planning and coping 
planning. Intention is expected to lead to long term action if one believes they 
are capable of maintaining the health behaviour (maintenance self-efficacy) 
and re-adopting it after relapse (recovery self-efficacy). 
Lay perceptions of disease risks and beliefs about preventive possibilities 
are closely linked to beliefs about how different diseases are like and how they 
evolve. The theoretical perspective of lay illness representations 
conceptualizes how people make sense of various diseases. The perspective of 
illness representations has been found useful for examining lay perspectives 
on predictive genetic testing (van Oostrom et al., 2007b). 
2.2 ILLNESS REPRESENTATIONS 
Health professionals have detailed information on different diseases, but 
research suggests that lay people make sense of different diseases through 
more general aspects that apply to all types of diseases. The Common Sense 
Model (CSM) of illness representations suggests that lay people make sense of 
diseases through five general dimensions (Hagger & Orbell, 2003; Leventhal 
et al., 1980). These dimensions are cause, consequences, illness identity, 
timeline, and cure/controllability.  
The cause dimension includes knowlegde and beliefs about what causes the 
given disease. Multifactorial diseases have several causes – health behaviour, 
environmental exposures, and genetics. Even when professionals and lay 
people agree on the factors that contribute to certain illnesses, they may 
emphasize each factor differently (Damman & Timmermans, 2012). Causes 
may also include psychological explanations like personality or stress (Moss-
Morris et al., 2002). The consequences dimension captures beliefs about how 
the illness affects one’s quality of life and functional capacity. Illness identity 
refers to how the illness is labeled and what its symptoms are; whether it is 
seen as a coherent entity that makes sense (Moss-Morris et al., 2002). 
Timeline concerns individual’s beliefs about the course of illness, e.g. whether 
it is chronic and how its symptoms progress. The cure/controllability 
dimension includes beliefs about whether and how the illness can be treated: 
whether and how it may be cured or how its symptoms may be alleviated 
(Hagger & Orbell, 2003).  
These five dimensions are expected to be used for making sense of all types 
of diseases. The CSM has been used in research on various types of diseases, 
including cardiovascular diseases (French, Cooper, & Weinman, 2006), 
hereditary cancer (Kelly et al., 2005), neurological disorders such as dementia 
(Hamilton-West, Milne, Chenery, & Tilbrook, 2010), and psychiatric disorders 
such as depression (Fortune, Barrowclough, & Lobban, 2004). There is also 
some evidence that these dimensions interact with each other. For example, if 
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a disease is perceived to be caused by genetics, people tend to consider 
biological preventive methods more efficient compared to behaviour based 
methods (Senior & Marteau, 2007), and this may also depend on the type of 
disease (Wright et al., 2012). A strength of the CSM is that it acknowledges the 
role of people’s previous experiences of diseases, and that individuals have an 
active role in making sense of potential health outcomes of their behaviour 
(Harvey & Lawson, 2009). 
Illness representations are also likely to influence people’s preferences for 
which types of secondary findings they wish to receive, and this needs to be 
taken into account in genetic counselling (Shiloh, 2006). Previous quantitative 
research also suggests that illness representations are likely to contribute to 
ways of cognitive and emotional coping with predictive genetic risk 
information (van Oostrom et al., 2007b): serious consequences and long 
duration of the illness and and an ambiguous illness identity seem to promote 
distress and various coping behaviours. Dimensions of illness representations 
have been shown to predict attending treatment (French et al., 2006). This 
suggests that changing illness representations may also change, for example, 
treatment seeking. When people receive new risk information such as genetic 
secondary findings, they may use their illness representations to make sense 
about what it means for their life. Receiving secondary findings may also shift 
illness representations when one receives more detailed information on the 
disease in question. 
2.3 CONCEPTUAL FRAMEWORK OF THE STUDY 
The conceptual framework of this study combines perspectives of health 
behaviour theories on risk perceptions and illness representations (Figure 1), 
which are described above. In this study, perceived risk of disease is 
understood as a multidimensional construct that combines 1) perceived 
likelihood and 2) perceived severity of the disease. Perceived likelihood means 
an individual’s evaluation of the odds that they will develop the disease in 
question (low/high). Perceived severity is conceptualized to consist of a) 
severity of the illness in medical terms (e.g. mortality, severity of symptoms) 
and b) severity in terms of lived experience of the disease, which includes how 
the illness may affect personal life and social relations (e.g. quality of life, 
stigma). Perceived severity in medical terms and as lived experience are seen 
as overlapping. By making this distinction I want to emphasize that severity of 
illness has many different aspects for a lay person who not only looks at the 
illness from the perspective of how and how efficiently it could be treated 
(medical perspective) but also how the illness would integrate into one’s life as 
a whole. 
In this study, several factors are expected to contribute to perceived risk. 
Perceived likelihood of disease is expected to follow from disease risk 
indicators, such as family history of the disease, health behaviour, 
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physiological risk indicators such as body weight and biomarkers (e.g. blood 
sugar), and genetic risk indicators such as secondary findings. Perceptions of 
severity of the disease, on the other hand, are expected to follow from illness 
representations. I consider that family history – previous experience of the 
disease – has potential to contribute to individuals’ representations of 
different illnesses. Family history is hence expected to directly contribute to 
perceived likelihood and indirectly to perceived severity through illness 
representations. 
The conceptual framework expects health behaviour to contribute to 
perceived risk, and vice versa. Changes in health behaviour may also shift 
physiological risk indicators. People are expected to re-adjust their risk 
perceptions when their risk indicators change, and also to reduce their risks 
by preventive actions when they perceive risk of disease. 
 
 
 
 
Figure 1 The conceptual framework of the study. 
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 REVIEW OF EMPIRICAL LITERATURE 
This literature review briefly describes empirical research concerning family 
history, disease risk perception, and health behaviour, as well as reactions to 
genomic secondary findings. Health psychological research has widely studied 
relationships of perceived risk of various health outcomes and different types 
of health behaviour (Sheeran, Harris, & Epton, 2014; Zhang, Schwarzer, 
Zhang, & Hagger, 2018). This review focuses on those theoretical models and 
health behaviours that are most relevant for the current study.  
Risk perceptions tend not to be accurate evaluations calculated by objective 
risk factors (Adriaanse et al., 2008; Katapodi, Lee, Facione, & Dodd, 2004). In 
general, people tend to be optimistic about their future health, and they also 
tend to see their current health behaviour in favourable light (Rothman & 
Kiviniemi, 1999; Weinstein, 1984). Risk perception may be measured in 
absolute or comparative terms. Absolute measures may assess, for example, 
10-year or lifetime risk perception on a five-point scale from very low to very 
high, or numerical scale from 0–100. Comparative risk perception measures 
risk relative to peers of the same sex and age; these tend to correlate 
moderately (Lipkus et al., 2000), and physiological risk indicators tend to 
associate more strongly with the absolute measures of perceived risk (Godino, 
van Sluijs, Sutton, & Griffin, 2014). 
3.1 FAMILY HISTORY AND PERCEIVED RISK 
Lay people tend to understand heritability as diseases and traits ‘running in 
families’, instead of a more detailed understanding of the structural and 
functional nature of genes (Condit, 2010a; Jallinoja & Aro, 1999). People 
acknowledge that diseases that run in the family may be caused by genetics 
and/or health behaviours which are shared by family members (Condit, 
2010a). Those who are aware of the role of genetics are also more aware of the 
role of lifestyle in disease etilogy (Sanderson, Waller, Humphries, & Wardle, 
2011). It has also been observed that perceived risks of different diseases tend 
to overlap (DiLorenzo et al., 2006), which could partly be explained by 
cognitive tendencies to view one’s future health optimistically or 
pessimistically. 
In previous studies, family history has had a strong association with 
perceived personal risk of CVD, type 2 diabetes and cancer (Acheson et al., 
2010; DiLorenzo et al., 2006; Montgomery, Erblich, DiLorenzo, & Bovbjerg, 
2003; Wang et al., 2012). Concerns have been expressed that knowledge of 
genetic risk could lead to fatalism and discourage any preventive health 
behaviour. However, empirical studies suggest that being aware of a familial 
or genetic risk for multifactorial diseases might have little impact on control 
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beliefs (Collins, Wright, & Marteau, 2011). Some studies even suggest it might 
increase feelings of control over the risk (McVay et al., 2015; Pijl et al., 2009) 
and incourage preventive action, including information seeking, screening 
attendance, and lifestyle changes (Hariri et al., 2006).  
Research is still needed on whether family history is related to perceived 
risk independently of health behaviour. Also, previous studies have not 
explicitly compared the strength of this association across diseases in the 
general population. Furthermore, little is known about how family history 
contributes to perceived risks of psychiatric disorders, such as depression. 
There is some evidence that lay people are better aware of the social 
environmental risk factors of depression than the genetic component (Jorm et 
al., 1997), but it is unclear whether family history of depression contributes to 
perceived personal risk of depression. Family history and health behaviour 
could contribute to perceived risk differently across different types of diseases, 
which could have implications for risk education. Associations between family 
history and perceived risks of common diseases were examined in sub-study I 
of this thesis. 
3.2 PERCEIVED RISK AND HEALTH BEHAVIOUR 
Educating patients and the public about disease risks is a common health 
promotion strategy. However, risk perceptions are relatively resistant to new 
information and tend not to change easily (Wang et al., 2012), since people 
may psychologically reject or minimize personal relevance of risk information 
(Rothman & Kiviniemi, 1999; Vähäsarja et al., 2015). People may be self-
defensive when faced with negative information (Gerrard et al., 1998; Wright, 
2010), but they are also more likely to question reliability of risk information 
if it contrasts their expectations, regardless whether it is positive or negative 
(Renner, 2004). Some longitudinal studies provide evidence that people 
readjust their risk perceptions after they change their risk-related behaviour 
(Brewer, Weinstein, Cuite, & Herrington Jr, 2004; Renner, Schüz, & 
Sniehotta, 2008), but a recent review of 36 studies shows that simply 
providing personalized risk feedback usually does not lead to sustained health 
behavior change (French et al., 2017). Another systematic review of 
communicating coronary risk concluded that risk information may increase 
accuracy of risk perceptions and lead to preventive intentions, if it is repeated 
and combined with counselling, but simply providing risk estimates on a single 
occasion seems ineffective (Sheridan et al., 2010). 
Health psychological research has widely examined the relationship of 
perceived risk and different types of health behaviour (Zhang et al., 2018), 
including getting vaccinated (Brewer et al., 2007), attending screenings 
(Katapodi et al., 2004), condom use (Foss, Hossain, Vickerman, & Watts, 
2007), or physical activity and diet (Gholami, Knoll, & Schwarzer, 2014). 
Overall, previous evidence supports that perceived risk contributes to health 
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related behaviour, but its effect is likely to depend on the type of health 
behaviour. Risk perception seems to promote most clearly behaviours whose 
consequences are most clearly health related (Wright, 2010). For example, 
attending cancer screening or getting vaccinated is a more clearly defined 
health act, compared to physical activity or dietary behaviours that are 
integrated into people’s daily social lives in complex ways. 
There are also several studies that examined whether receiving biomarker 
based health feedback promotes health behaviour intentions. According to a 
review of randomized controlled trials (McClure, 2002), biomarker feedback 
may motivate health behavior change, but results from these studies are 
mixed. The review authors point out that these studies mostly used potentially 
biased retrospective self-report measures of behaviour change, and most of the 
studies did not measure risk perceptions, which could be the mechanism 
through which feedback motivates change. Feedback of physiological risk 
indicators of common diseases most likely needs to be combined with 
behavioural treatment (McClure, 2002), since lifestyle changes such as 
increasing and maintaining higher levels of physical activity or losing weight 
require sustained efforts. A recent review also concluded that communicating 
polygenic risks for multifactorial diseases tends not to result in health 
behaviour changes (Hollands et al., 2016). 
Previous literature that examined physical activity using the HAPA model 
suggests that self-efficacy and outcome beliefs are more likely to promote 
intention to be physically active, whereas risk perception seems not to promote 
intention to be physically active (Gholami et al., 2014). Furthermore, intention 
to be physically active has an effect on actually being physically active 
(Gholami et al., 2014). Other studies, which looked at health behaviours more 
generally, concluded that risk perception had effects on health behaviour, but 
these effects were smaller than those of self-efficacy and outcome beliefs 
(Zhang et al., 2018). Self-efficacy has been linked with successful weight 
management in various intervention studies (Teixeira et al., 2015). A review 
on experimental studies, which looked at health behaviour in general, showed 
that risk appraisals did have small effects on intentions and health behaviour, 
and self-efficacy and outcome beliefs strengthened these effects (Sheeran et 
al., 2014). 
Overall, previous literature suggests that risk perception has its place in 
behaviour change, but its role is likely to depend on the type of health 
behaviour in question, as well as other factors, such as self-efficacy and 
outcome beliefs. Hence, risk perception needs to be examined together with 
self-efficacy and outcome beliefs. As a result of health behaviour change, also 
physiological risk indicators such as body mass index (BMI) and blood glucose 
may change. However, no longitudinal studies have simultaneously assessed 
how perceived risk of chronic diseases, self-efficacy and outcome beliefs 
together relate to health behaviour and physiological risk indicators. This 
thesis addressed bi-directionality of perceived risk and risk indicators in sub-
study II. 
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3.3 COMMUNICATING GENETIC RISKS: SECONDARY 
FINDINGS 
 
Communicating traditional risk factors of chronic diseases has long traditions. 
Advances in genomics add a possibility to include genetic risks in risk 
communication. Genome sequencing makes it possible to calculate polygenic 
risk scores for multifactorial diseases, and to combine this information with 
traditional risk indicators, such as health behaviour, biomarkers, and family 
history. At the same time, however, genome sequencing raises the possibility 
to detect secondary findings that were not the primary target of the 
investigation: single variants that indicate high risks for heritable conditions.  
Risks indicated by secondary findings differ from many other types of risk 
information in several ways. First, a single genetic variant may impose a high 
disease risk on its own, whereas polygenic risk scores usually impose less 
drastic   changes to risk estimates based on traditional risk factors. Second, 
dominantly inherited high-risk variants concern also one’s family members 
more clearly, since each first-degree family member has a 50% chance of 
having the same variant. Hence, individuals may feel strongly responsible for 
their family members in that situation (Vavolizza et al., 2015). Third, since 
secondary findings are ‘secondary’, they were not what was primarily expected 
from the analysis: the finding may be completely unexpected. In case of a 
clinical investigation, the primary target of a genomic analysis could be, for 
example, to diagnose a child who has a disability. A secondary finding could 
be, for example, a variant indicating high risk for cancer. This finding would 
have implications for the whole family, and it could be received in a situation 
where the family is already preoccupied by the child’s current condition. Due 
to these complexities, a lot of discussion has been going on around how 
secondary findings should be handled in research settings and clinical 
practice. 
Since there are dozens of possible secondary findings to be reported from 
genome sequencing, a lot of discussion has focused around what would be the 
best way to insure valid informed consent to receiving them (Appelbaum et al., 
2014; Berg et al., 2011; Bunnik et al., 2012; Mackley et al., 2016). Traditionally, 
genetic testing for disease has been preceded with thorough counselling about 
the risk, the disease, and their implications. This practice aids individuals to 
make an informed decision on whether or not to have the test (Riley et al., 
2012). Since it is not practical to provide extensive information on dozens of 
possible secondary findings, suggestions have been made about how 
secondary findings could be categorized, so that people could choose, which 
types of secondary findings they would like to receive (Appelbaum et al., 2014; 
Berg et al., 2011). These suggestions tend to conclude that secondary findings 
should be categorized based on severity of disease and efficiency of available 
preventive methods (Berg et al., 2011). It has also been suggested that 
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secondary findings linked to somatic and psychiatric diseases should be 
separated (Bunnik et al., 2012).  
Overall, lay people seem to view positively the practice of reporting genetic 
secondary findings (Bollinger, Scott, Dvoskin, & Kaufman, 2012; Daack-
Hirsch et al., 2013; Haukkala et al., 2013; Loud et al., 2016; Ormondroyd et 
al., 2007). Their preferences tend to be in line with professionals views in that 
majority prefers to know actionable secondary findings, however, their 
definitions of ‘actionable’ may differ from professional definicions of 
preventability and treatability (Mackley et al., 2016). To lay people, 
‘actionability’ may also mean ability to plan one’s life course or to help close 
ones prepare for the illness on time. Hence, for lay people, ‘actionability’ of 
secondary findings may be an ambiguous criterion when asking for consent to 
receive secondary findings (Jamal et al., 2017). 
Research participants are usually positive towards receiving medically 
actionable secondary findings (Facio et al., 2013; Loud et al., 2016; Murphy et 
al., 2008). In fact, majority tend to respond that they wish to receive not only 
actionable but all possible results: those could be related to e.g. ancestry, 
pharmacogenetics, cardiovascular diseases, cancers, depression, Alzheimer’s 
disease, Huntington’s disease, or carrier status of recessive diseases (Wynn et 
al., 2017). In contrast to what professionals might expect, knowing one’s risk 
for a non-actionable, progressive disease like Alzheimer’s disease is not always 
perceived as most distressing, for example if one has reassuring previous 
experience of dealing with the illness, or if one believes that treatment 
methods will be available in the future (Jamal et al., 2017). 
Several studies have examined research participants’ reactions to genomic 
results (Hallowell et al., 2013; Haukkala et al., 2013; Lewis et al., 2016; 
McBride et al., 2016; Ormondroyd et al., 2007; Sanderson et al., 2017). In 
some studies that reported actionable secondary findings related to cancer or 
heart diseases, participants reacted positively and found the information 
useful (Haukkala et al., 2013; Lewis et al., 2016), but in other studies reactions 
to unexpected genetic risk information were more ambivalent (Hallowell et al., 
2013; Ormondroyd et al., 2007). Qualitative research suggests that 
perspectives on secondary findings vary greatly according to individual life 
situations (McBride et al., 2016). Research is still needed on what types of 
support people need after receipt of secondary findings, and how these needs 
could be addressed in different contexts, as e.g. structure of health care system 
varies in different countries. This thesis addressed these issues in qualitative 
sub-studies III and IV.  
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 STUDY AIMS 
The general aim of this study was to examine lay perspectives on risks of 
common diseases and secondary findings of genome sequencing. Quantitative 
sub-studies I and II examined relationships between family history, perceived 
risk, physiological risk indicators and health behaviour among the general 
population. Qualitative studies III and IV focused on a specific situation of 
receiving genetic risk information. These studies explored lay perspectives on 
receiving different types of health related secondary findings from genome 
sequencing. Aims and research questions of each sub-study are detailed below. 
Sub-study I: Is family history related to perceived risk of diabetes, CVD 
cancer, and depression? Are these associations similar across diseases, and 
independent of sociodemographics, BMI, health behaviour, and current 
depressive symptoms? 
Sub-study II examined longitudinal associations of perceived risks and 
risk indicators over five years, among two samples with a different diabetes 
risk status. Does perceived risk of diabetes or CVD predict physical activity, 
BMI or blood glucose? Or rather, does physical activity, BMI or blood glucose 
predict perceived risk of diabetes or CVD? The study further examined how 
perceived risk, self-efficacy, and outcome beliefs together predicted changes in 
risk indicators. 
Sub-study III explored Finnish adults’ perspectives on the reporting of 
genetic secondary findings via letter. What are lay people’s concerns and needs 
related to receiving genetic secondary findings that are linked to serious but 
actionable conditions? 
Sub-study IV focused on meanings of different diseases in the context of 
secondary findings. How do lay people react to different types of hypothetical 
genomic secondary findings? In which ways does the type of disease matter 
when receiving genetic secondary findings? 
This study used both quantitative (sub-studies I and II) and qualitative 
methods (sub-studies III and IV) to gain general understanding of risk 
perception in relation to risk indicators, and nuanced understanding of lay 
perspectives on hereditary risk information. There are several ways in which 
qualitative and quantitative methods may be combined (Johnson, 
Onwuegbuzie, & Turner, 2007), of which this study considers these 
approaches as complementary. Quantitative methods were used to gain an 
overall understanding of how lay people evaluate their risks for multifactorial 
diseases, whereas qualitative methods were used to gain detailed insight into 
how people make sense of new genetic risk information. Since the topics of 
quantitative and qualitative sub-studies were somewhat different, quantitative 
and qualitative data were not triangulated during the analysis process. 
However, these perspectives are seen as complementary when interpreting the 
study results. 
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 QUANTITATIVE METHODS 
Quantitative methods were used to gain an overall understanding of how 
family history, behavioural and physiological risk indicators, and depressive 
symptoms relate to perceived risks of common diseases among the Finnish 
adult population (sub-studies I and II). Main statistical methods were 
multivariate regression analyses and structural equation modelling.  
5.1 PARTICIPANTS 
The quantitative sub-studies I and II used national FINRISK health 
examination and survey data collected by the National Institute for Health and 
Welfare. FINRISK (The National Cardiovascular Risk Factor Survey) is a 
population study on chronic disease risk indicators that has been carried out 
every five years since 1972. The study uses independent, random and 
representative population samples from various areas of Finland. Sub-study I 
used a cross-sectional data of a nationally derived sample. Sub-study II used 
two sub-samples with a different diabetes risk status, who were followed-up 
during a five-year period. Research protocols were designed and conducted in 
accordance with the Declaration of Helsinki guidelines for research with 
human participants, and approved by the Ethics Committee of the Hospital 
District of Helsinki and Uusimaa. Each study participant gave a written 
informed consent. 
5.1.1 FINRISK 2007 
Participants of sub-study I were 25–74-year-old Finnish men and women who 
attended the National FINRISK 2007 study (Vartiainen et al., 2010). The study 
was conducted between January–March 2007. The study derived a random 
sample of 10 000 people from the population registry. The sample was 
stratified by gender, ten-year age-groups, and five geographical regions. 
Participation rate of the study was 63% (N=6258). People were invited to 
participate via letter, which invited the recipient to attend a health 
examination at a municipal health care centre. Attached to the letter was a 
questionnaire, which the recipient was asked to fill in at home and return when 
attending the health examination. The questionnaire included 
sociodemographics, medical history, health behaviour, life satisfaction, social 
trust, and family history and personal risk perceptions of common diseases: 
diabetes, CVD, cancer and depression.  
In April–June 2007, all participants of FINRISK 2007 were invited to 
attend the Dietary, Lifestyle and Genetic determinants of Obesity and 
Metabolic syndrome (DILGOM) sub-study (N=5024, response rate: 80 %) 
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(Konttinen, Silventoinen, Sarlio-Lähteenkorva, Männistö, & Haukkala, 2010). 
This study included a health examination and several questionnaires, 
including a scale for depressive symptoms (Radloff, 1977). Sub-study I used 
the data from DILGOM study for analyses that concerned depressive 
symptoms. 
5.1.2 FINRISK BLOOD GLUCOSE STUDY 2002–2007  
Sub-study II participants were from the FINRISK 2002 study, which 
examined cardiovascular risk factors (Laatikainen et al., 2003). FINRISK 
2002 study procedure resembles that of FINRISK 2007, which was used in 
sub-study I. FINRISK 2002 picked a random sample of 13 500 people from 
the population registry – stratified by gender, ten-year age-groups, and six 
geographical regions. By mail, people were invited to fill in a survey and 
participate a health examination in January–March 2002. After the health 
examination, participants received a feedback letter, which reported several 
biomarkers, e.g. their cholesterol levels and blood pressure. The letter also 
described normal scores for each measure, and what the participant could do 
to achieve normal scores, if their personal values were not within the normal 
range. These advice contained recommendations for dietary changes, losing 
weight, increasing physical activity, or contacting their personal doctor. 
FINRISK 2002 participants of age 45–74 years (N=3513) were invited to 
participate FINRISK Blood Glucose study later in the spring of the same 
year, in April–June 2002. This study contained a 2-hour glucose tolerance 
test and a diabetes risk factor questionnaire (Lindström & Tuomilehto, 
2003). Participants (N=2558, participation rate 73%) received feedback of 
their fasting plasma glucose, 2-hour glucose, and insulin level via another 
feedback letter. The letter adviced the participant to have their glucose level 
re-measured, if their fasting glucose level exceeded 6.0 mmol/l, or if their 2-
hour glucose exceeded 7.8 mmol/l, since these are considered elevated levels. 
The participant was adviced to contact a physician if their fasting glucose 
exceeded 7.0 mmol/l, or if their 2-hour glucose exceeded 11.1 mmol/l. These 
latter values are diagnostic criteria for diabetes, but individual diagnosis 
requires repeating the measurements (WHO, 1999), this information was not 
provided in the letter. In addition to these recommendations, the letter 
described that increasing exercise, decreasing fat intake, increasing fibre 
intake, or weight loss down to normal weight are means to reduce mildly 
elevated blood glucose. 
Five years later in 2007, all FINRISK Blood Glucose Study participants 
who had a high risk for diabetes were invited to a follow-up. Diabetes risk 
was evaluated based on blood glucose measures, diabetes risk factor 
questionnaire (Lindström & Tuomilehto, 2003), or current or previous CVD. 
Participation rate was 80% (N=432). In addition, a random sample of those 
participants who were not classified as having high risk for diabetes were 
invited to the follow-up. Participation rate for this low/moderate risk sample 
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was 84% (N=477). The follow-up study 2007 included another survey and 
health examination with a new 2-hour glucose tolerance test. Sub-study II 
used these two sub-samples with a different diabetes risk status. 
5.2 MEASURES 
Perceived risks of diabetes (sub-studies I and II), CVD (I and II), cancer (I), 
and depression (I) were measured with single items: ‘How do you perceive 
your own risk of developing [disease] in your lifetime?’ 0=I have [disease], 
1=very low, 2=low, 3=moderate, 4=high, 5=very high. A similar five-point 
scale has shown high correlation with a more continuous measure of perceived 
absolute risk during lifetime, and moderate correlation with perceived risk 
compared to other people of the same gender and age (Godino et al., 2014). 
In sub-study I, participants who self-reported CVD (N=292), diabetes 
(N=191), severe depression (N=61), or previous or current cancer (N=184) 
were excluded from analyses concerning that disease. Similarly in sub-study 
II, those who self-reported diabetes/CVD were excluded from analyses where 
the relevant measure was used (diabetes at baseline: N=1 among high risk 
sample; at follow-up: N=2 among low/average risk sample, N=38 among high 
risk sample. CVD at baseline: N=20 among low/average diabetes risk sample, 
N=35 among high risk sample; at follow-up N=29 and N=36, respectively). 
Family history (I) of diseases were assessed using sum variables that 
combined items concerning diagnosed diseases among first-degree family 
members. Family history of CVD consisted of whether a) father, b) mother, c) 
one or more brothers d) one or more sisters of the participant had had a 
myocardial infarction before the age of 60 (in case of mother 65). Family 
history of diabetes, cancer and depression consisted of whether a) father, b) 
mother, c) one or more brothers, d) one or more sisters had a diagnosis for 
that disease. Hence, available scale for each family history variable was 0–4.  
Health action self-efficacy (II) was assessed with six items (reponse 
choices from 1=very uncertain to 4 completely certain): ‘How certain are you 
that… 
…you can take health perspective into account when planning your life and 
making decisions about it? 
…you manage to follow your decisions on starting a new, healthier life? 
…you manage to follow healthy lifestyle, even if people around you would not 
care about it? 
…you can resist temptations when you know they harm your health? 
…you manage to care about whether something is harmful for health or not, 
even if you are busy, tired, or under a lot of pressure? 
…you can take health perspective into account, even if it would be inconvenient 
or you would have to give up other things that are important to you? 
 The questionnaire included three additional items that were excluded: one 
concerned smoking and another one adherence to health examinations, which 
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were not directly relevant for the study outcomes. One item was ambivalent in 
terms of content, whether it concerned self-efficacy or outcome beliefs. Self-
efficacy was used as a latent variable in the analyses. Test of the combined 
measurement model of self-efficacy and outcome beliefs is presented in the 
results (section 7.2). 
Outcome beliefs (II) were assessed with three items:  
‘How certain are you that serious illnesses such as heart diseases, cancer or 
diabetes can be prevented by healthy lifestyle?’ (1=very uncertain to 
4=completely certain). 
‘Heart diseases can be prevented by healthy lifestyle’ (1=strongly disagree to 
5=strongly agree). 
‘Changing diet at middle age is not worth it anymore’ (1=strongly disagree to 
5=strongly agree, reversed).  
The questionnaire also included an item concerning whether it is worth it 
to change lifestyle if one is already ill, but this was excluded as it would not be 
relevant among a currently healthy population. Also outcome beliefs was used 
as a latent variable.  
Physical activity (I and II) was measured slightly differently in sub-
studies I and II. In sub-study I, the following item was used: ‘How much do 
you exercise and strain yourself physically in your free time?’ 1=reading, 
television or physically non-exhausting work at home (sedentary), 2=walking, 
cycling or similar at least 4 h/week excluding travel to work (moderately 
active), 3=vigorous exercise or work at least 3 h/week and 4=competitive 
training of strenuous sports several times a week (active, combined for group 
comparisons). This four-point measure correlates moderately with 
accelerometer counts among the working age population, and its criterion 
validity against morbidity and mortality is good (Fagt et al., 2011).  
In sub-study II, a different single item was used: ‘How many times a week, 
in your free time, do you exercise so that you experience at least mild 
exhaustion and sweating?’ At follow-up, the question specified that each 
reported exercise time should take at least 20 minutes. Also response choices 
were added: 1=I cannot exercise due to illness or injury (excluded from 
analyses concerning physical activity, low/moderate risk sample N=13, high 
risk sample N=38), 2=less than once a week, 3=once a week … 7=five times a 
week or more. For the analyses, both measures were coded as ‘physical 
activity’: 0=less than once a week, 1=once a week, 2=twice a week, 3=three 
times a week, 4=four times a week, 5=five times a week or more. 
Smoking (I) included three categories, 1=never smokers, 2=former 
smokers and 3=current smokers. Current smoking was defined as smoking 
regularly more than once a day for at least one year, including the preceding 
month.  
Alcohol consumption (I) was measured as grams of pure alcohol per 
week during the past 12 months. This was calculated based on participants’ 
responses to questions that asked about how frequently and how much they 
consumed different alcoholic beverages (Dufi’y & Alankoz, 1992). Skewness 
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(4.55) and kurtosis (28.07) of the distribution were reduced by using square 
root transformation before correlative and regression analyses were 
conducted. 
Body mass index (BMI kg/m², I and II) was calculated based on weight 
and height, which were measured by trained research nurses. 
2-hour plasma glucose (II) was measured in sub-study II health 
examinations at baseline and at follow-up. At baseline 2002 and at follow-up 
2007, participants attended glucose tolerance tests, which were conducted 
according to WHO guidelines (11). After a 12-hour fast, each participant drank 
300 ml solution with 75 g anhydrous glucose and 1.6 g citric acid. Blood sample 
was drawn after two hours for testing glucose level. (Borodulin, 2006) 
Compared to fasting glucose, 2-hour glucose predicts progress of diabetes 
more sensitively (Saaristo et al., 2010; Shaw et al., 1999), this is why 2-hour 
glucose was chosen as an outcome measure for the study. 
Depressive symptoms (I) were assessed using the Center for 
Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977). CES-D is a 
brief, structured self-report measure, which is not a diagnostic tool, but 
instead was developed for measuring depressive symptoms among the general 
population. The measure emphasizes the affective component of depression, 
i.e. depressed mood. The scale includes twenty statements that express 
feelings or behaviour during the past week, e.g. ‘I felt that everything I did was 
an effort’ and ‘I was happy’ (reversed). Response choices are ‘Rarely or none 
of the time (less than 1 day)’, ‘Some or a little of the time (1–2 days)’, 
Occasionally of moderate amount of the time (3–4 days)’, and ‘Most or all of 
the time (5–7 days)’. In the current study, number of days were not included 
in the response choices, but only the verbal descriptions. 
Education years (I) were assessed using a single item: ‘How many years 
have you attended school or studied full time altogether?’  
 
5.3 STATISTICAL ANALYSES 
The main statistical methods were multivariate regression analysis in sub-
study I and structural equation modelling in sub-study II. These were 
conducted using SPSS Statistics version 24 and SPSS Amos Graphics version 
24 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used to explore 
distributions, means, and standard deviations of the study variables. 
5.3.1 MULTIVARIATE REGRESSION ANALYSES 
In sub-study I, bivariate correlations between study variables were examined 
using Pearson’s correlation coefficients. We tested whether the correlation 
between family history and perceived risk was similar across diseases – 
diabetes, CVD, cancer, and depression. To test these, a calculation to test the 
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difference between two independent correlation coefficients was used 
(Preacher, 2002). 
Sub-study I used multivariate regression analyses to examine whether 
family history (step 1), sociodemographics (gender, age and education, step 2), 
health behaviours (physical activity, smoking, alcohol consumption) and BMI 
(step 3), and depressive symptoms (step 4) explained perceived risk. These 
models were performed separately for each disease. Gender (0=men, 
1=women) and smoking (0=never smokers/ex-smokers, 1=current smokers) 
were used as dichotomous variables in the correlative and regression analyses. 
All other variables were used as continuous variables. 
To test whether sociodemographics, health behaviours, BMI, or depressive 
symptoms moderated the association between family history and perceived 
risk, separate models were used for each tested moderator. Each model 
contained main effects in step 1, and the interaction term in step 2. For 
education, also age was included in the first step, to take into account that the 
general education level has increased in Finland during the past decades. For 
smoking, current smokers and former smokers were compared against never 
smokers. For physical activity, moderately active and active participants were 
compaired against sedentary participants. 
5.3.2 STRUCTURAL EQUATION MODELLING 
In sub-study II, the main analytical approach was structural equation 
modelling, SEM (Lomax & Schumacker, 2004). This approach had several 
advantages in the current study: it allows multiple-group analyses, takes into 
account covariation of multiple predictors, and allows the use of latent 
variables, which reduces the effect of measurement error. All SEM models 
were adjusted for age and gender, and tested separately among the high 
diabetes risk sample and the low/moderate risk sample.  
Longitudinal associations of perceived risk of diabetes/CVD and risk 
indicators (physical activity, BMI, 2-hour glucose) were examined using cross-
lagged autoregressive models. Multigroup analyses were used to test whether 
the associations were similar among those with a high diabetes risk and among 
those with a low/moderate risk. Fit of cross-lagged models were not evaluated, 
as these were saturated models with zero degrees of freedom.  
SEM was further used to test how perceived risk of diabetes, self-efficacy 
and outcome beliefs in 2002 predicted physical activity, BMI, or glucose level 
in 2007 (adjusted for baseline level of outcome variable). Similar models were 
performed to test how perceived risk of CVD, self-efficacy, and outcome beliefs 
in 2002 predicted physical activity and BMI in 2007. These models were 
evaluated using the following fit indexes: ǒ² statistic, Comparative Fit Index 
(CFI), Tucker-Lewis Index (TLI), and Root Mean Square Error of 
Approximation (RMSEA) (Hu & Bentler, 1999). In all these models, self-
efficacy and outcome beliefs were latent variables. The combined 
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measurement model of self-efficacy and outcome beliefs was tested before 
these SEM models were performed (see section 7.2). 
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 QUALITATIVE METHODS 
Qualitative methods were used to explore lay perspectives on secondary 
findings of genome sequencing. The qualitative approach was chosen to reveal 
nuanced experiences and meanings around the study topic. The qualitative 
sub-studies III and IV were based on a vignette study design (Barter & Renold, 
1999), which included written reactions to hypothetical secondary findings, 
and focus group discussions (Barbour, 2008). The study is based on realist 
epistemology: the assumption is that written accounts and discussions are able 
to reveal something about ‘experiences, meanings and the reality of 
participants’ (Braun & Clarke, 2006). The study design was informed by the 
research tradition of Eskola’s method of empathy-based stories, which has 
been used in Finnish social and educational research from the 1970s onwards 
(Eskola, 1998; Wallin, Helenius, Saaranen-Kauppinen, & Eskola, 2015). When 
using this method, the researcher creates a few variations of a story, after 
which the research participants are asked a question, answer to which provides 
one way to complete the story. The method resembles experimental desing in 
that answers to the different variations of the story may be compared against 
each other. A central strength of this method is its ability to encourage new 
perspectives on study topics, since it allows participants to think freely (Wallin 
et al., 2015).  
The qualitative part of this study focused on four heritable diseases that all 
have autosomal dominant inheritance. In line with the method of empathy-
based stories, the study participants were represented with a hypothetical 
situation of receiving a letter that revealed a secondary finding from clinical 
whole genome sequencing. Four versions of the vignette letter were 
formulated, each reporting risk for a different disease. The chosen diseases 
included two cardiovascular syndromes – familial hypercholesterolemia (FH) 
and long QT syndrome (LQTS) – and two cancer syndromes – Lynch 
syndrome (LS) and Li–Fraumeni syndrome (LFS). These diseases were 
included in the study since they are all among the list of secondary findings 
that the ACMG recommends to be reported in clinical settings (Kalia et al., 
2016), but they vary in their severity and actionability. In addition, the 
research group had previous experience of reporting LQTS findings to biobank 
participants (Haukkala et al., 2013) and of contacting LS families via letter to 
invite them to have genetic testing (Aktan-Collan et al., 2007). 
FH causes increased blood cholesterol, which needs to be medically 
treated. If untreated, FH leads to early coronary artery disease (Youngblom, 
Pariani, & Knowles, 1993). FH is relatively common among the population: in 
Finland its prevalence is estimated to be at least 0.17%, but it remains 
undertreated (Lahtinen, Havulinna, Jula, Salomaa, & Kontula, 2015). The 
other heart-related condition at the study focus, LQTS, predisposes to 
potentially fatal cardiac arrhythmia, usually before the age of 20. 
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Approximately half of non-treated mutation carriers have no symptoms, and 
the condition can be treated by beta blocker medication or pacemaker (Alders, 
Bikker, & Christiaans, 1993). The estimated prevalence of LQTS carriers in 
Finland is 0.01%–0.05% (Marjamaa et al., 2009).  
The two cancer syndromes at the study focus differ in their actionability. 
LS predisposes to several cancers, particularly to early colorectal and 
endometrial cancers. However, colorectal cancer has efficient surveillance 
possibilities: mutation carriers are recommended to attend colonoscopy every 
1–3 years (Kohlmann & Gruber, 1993; Seppälä, Pylvänäinen, Evans, et al., 
2017), so that the neoplasia can be found and removed before they progress 
into cancer. Prevalence of LS carriers in Finland is around 0.0005–0.001% 
(Mecklin & Järvinen, 2007). The other cancer syndrome at the focus of this 
study, LFS, is a more rare syndrome, which predisposes to several types of 
cancers – e.g. soft tissue sarcoma, osteosarcoma, pre-menopausal breast 
cancer, brain tumors, adrenocortical carcinoma, and leukemias – early in life, 
potentially already in childhood, and risk for multiple primary tumours is 
increased (Schneider, Zelley, Nichols, & Garber, 1993). Compared to LS, 
surveillance is less efficient, but mutation carriers are recommended 
comprehensive physical examinations annually, women are recommended 
annual breast magnetic resonance imaging and twice annual clinical breast 
examination, also prophylactic mastectomy and colonoscopies are options. 
Those who have the mutation predisposing to LFS have a 19% risk for cancer 
by the age of 30, and 90% risk by the age of 60. (Schneider et al., 1993) 
The vignette letters that were used in the current study did not contain all 
the information described above. The vignette letters resembled real life letters 
that were used in earlier studies (Aktan-Collan et al., 2007; Haukkala et al., 
2013). Before use, the vignettes were presented to and discussed with a pilot 
group of students. The research group considered that in real life, it would be 
unethical to reveal too detailed information on the diseases in a letter, since it 
could potentially cause excess distress. This is why the letters were quite brief 
and presented information at a general level: they did not describe risk 
percentages or worst-case outcomes. The four vignettes were parallel in their 
structure, but the level of detail for each disease varied slightly. The FH letter 
contained somewhat more detailed information on the condition, in order to 
convey that the condition is more severe than slightly elevated cholesterol 
level. Participants were given more information about the diseases during the 
focus group phase. 
Similar to the quantitative sub-studies, the Declaration of Helsinki 
guidelines for research with human participants were used when designing 
and conducting the qualitative study. Each participant gave their written 
informed consent. Protocols of qualitative sub-studies III and IV were 
approved by the University of Helsinki Ethical Review Board in the 
Humanities and Social and Behavioural Sciences.  
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6.1 NEWSPAPER RECRUITMENT 
Participants of the qualitative inquiry (sub-studies III and IV) were voluntary 
adults, recruited via Helsinki area Metro newspaper announcement on three 
days in May 2016, with the heading: ‘How should hereditary risk information 
be delivered?’ The announcement called for 18–64-year-old volunteers. Our 
research group was contacted by 32 people who were interested to participate 
and received a brief online survey. The survey was filled in by 29 participants, 
of whom 23 also attended one of four following focus group discussion. 
Participants who completed both study phases were compensated with two 
cinema tickets each. Sub-study III used focus group discussions to explore 
perspectives on secondary findings in general, whereas sub-study IV included 
immediate written reactions to hypothetical secondary findings, and those 
parts of the same focus group discussions that concerned meanings of 
different diseases in the context of secondary findings. 
Out of the 32 people who were initially interested in participating the study, 
29 participants completed a survey on sociodemographics and a writing task, 
and 23 attended one of the four focus group discussions. Only two of the 
participants were male; both participated also the focus group phase. The 
sample included a few younger adults, yet most were middle-aged (age range 
20í64 years, mean 49). Out of all participants, 16 had own children, 12 had a 
university degree, and professions included e.g. entrepreneur, teacher, artist, 
salesperson, welder, accountant, archaeologist, nurse, and personal assistant. 
Family disease history was not systematically collected, but several 
participants brought up their family history of cancer, heart disease, or high 
cholesterol level during the focus group discussions. One of the participants 
was waiting to be genetically tested for a hereditary heart-related condition 
(other than LQTS or FH).  
Out of those who completed the survey and writing task (N=29), six 
participants did not attend the focus group phase. Participants needed not 
provide reasons for not participating, but a few participants mentioned they 
were ill at the time of the focus group discussion, or could not find a baby sitter 
for the time. These participants were all female and roughly the same age as 
the rest of the participants (age range 30–61, mean 44). Sub-study III explored 
perspectives on receiving secondary findings at a general level, whereas sub-
study IV explored meanings of different diseases in this context. 
 
6.2 WRITTEN REACTIONS TO VIGNETTE LETTERS 
The first phase of the procedure was a survey that was sent via e-mail. First, 
participants read a study info, and filled in a consent form online. Second, they 
filled in a brief sociodemographic survey. Third, participants were presented 
with a hypothetical scenario, which described a situation where they had 
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earlier had a medical examination for a non-specified reason. Participants 
were asked to imagine facing this situation in real life. The scenario described 
that their whole genome had been sequenced for a clinical investigation, and 
they had consented to receive also secondary findings in case there were any. 
Now, the letter said, there was a secondary finding predisposing the 
participant to one of the four diseases at study focus: LS, LFS, LQTS, or FH 
(randomly assigned). The letter briefly described the illness and its dominant 
inheritance, relevance to family members, possibilities for preventive 
treatment, and adviced the participant to contact health care. Fourth, the 
participants (N=29) wrote down what they would think and do if they faced 
this situation in real life. 
6.3 FOCUS GROUP DISCUSSIONS 
The second phase of the procedure was focus group discussions. Each 
participant (N=23) attended one of the four focus groups within seven days 
after completing the writing task. Each of the four sessions (duration: 94–125 
min, mean 114) contained 4–7 participants. During each session, half of the 
participants had written their reaction on a cancer risk letter, and half on a 
cardiovascular risk letter. During the session, all participants could read both 
letters and comment on both of them freely.  
I was the main facilitator of the focus group discussions, using a topic guide 
that covered first reactions to the letter, perceptions of disease and risk, 
searching for information, family, recommendations for implementation, and 
consent. Participants were encouraged to discuss the letter and the topic from 
various perspectives. Aktan-Collan co-facilitated the discussions, with the role 
of a medical expert and psychotherapist who could answer participants’ 
questions on the diseases during the discussion. In addition, she introduced a 
brief slide show (14–32 min, 13 slides), which provided more information on 
the two diseases under discussion. This slide show was presented after 
approximately 45 min of discussion, in order to observe whether perspectives 
on the secondary findings would change after receiving more information on 
the diseases in question. 
6.4 INDUCTIVE THEMATIC ANALYSIS 
The written reactions and verbatim transcribed focus group discussions were 
analysed using inductive thematic analysis, with the help of the step-by-step 
guide provided by Braun and Clarke (Braun & Clarke, 2006). This flexible 
method aims to identify, analyse, and report patterns, i.e. themes within a data 
set. A ‘theme’ is a pattern within the data; a pattern that reveals something 
meaningful in relation to the research question. The method of thematic 
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analysis is compatible with both realist and constructionist epistemology, of 
which the current study is rooted in the former. 
Sub-study III included the focus group discussions as data, whereas for 
sub-study IV we included the written reactions and those parts of the focus 
group discussions that concerned disease meanings. Sub-study III aimed to 
provide a rich description of the data set, whereas sub-study IV aimed to 
provide a more detailed account of disease meanings (Braun & Clarke, 2006). 
The analysis was inductive (data driven, ‘bottom-up’) in that it was not guided 
by theoretical premises; the data was not fitted to any pre-existing coding 
frames. The aim of the analysis was to reveal explicitly expressed opinions as 
well as to interpret implicitly expressed, underlying meanings (Braun and 
Clarke, 2006). 
According to the step-by-step guide by Braun and Clarke, the phases of 
thematic analysis are 1) familiarizing with the data, 2) generating initial codes, 
3) searching for themes, 4) reviewing themes, 5) defining and naming themes, 
and 6) producing the report. However, the process is not entirely linear but 
recursive, and different phases may overlap. I first read through the data 
entirely, to initially familiarize with it (step 1). Second, I systematically coded 
the data manually, writing codes for each bit of the data by hand on the 
transcript sheet margins (step 2). Third, I collected all the codes and created 
groups of codes that were related to each other, to form larger themes (step 3). 
Next, I discussed the content of the themes together with Aktan-Collan, who 
had also thoroughly familiarized with the data by reading it through several 
times. Aktan-Collan agreed with the content of the themes. I discussed the 
thematic map, presenting relationships between themes, together with Aktan-
Collan and Hallowell. Specifics of the themes and the overall thematic 
structure was discussed and agreed among Aktan-Collan, Hallowell, and 
myself (steps 4 and 5). Furthermore, Aktan-Collan and Hallowell commented 
on several versions of the reports I wrote, so that best extracts to convey 
meanings of different themes could be decided upon (step 6). With the help of 
Hallowell, I translated data extracts from Finnish to English during report 
writing. 
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 RESULTS 
Results of the quantitative sub-studies showed that family history contributed 
to perceived risk across diseases independently of sociodemographics, health 
behaviour, BMI, or depressive symptoms. The longitudinal results, however, 
showed that perceived risk reflected risk indicators but did not predict 
preventive behaviour change. Qualitative results showed that despite being 
positive towards the practice of reporting secondary findings, people were 
concerned about availability of counselling and preventive treatment, and 
these concerns varied across different diseases.  
7.1 FAMILY HISTORY AND PERCEIVED RISK 
Sub-study I examined how family history, health behaviour and BMI, and 
depressive symptoms were related to perceived risk of common diseases. This 
study used cross-sectional data from the FINRISK 2007 study. Descriptive 
characteristics of the study sample are presented in Table 1. Means of 
perceived lifetime risks of different diseases ranged between 2=low and 
3=moderate. Family history of cancer was the most common (36.7% reported 
at least one family member), followed by diabetes (28.4%), early myocardial 
infarction (25.3%), and depression (19.6%).  
Pearson’s correlation of family history and perceived risk was statistically 
significantly stronger for diabetes than any of the other diseases (r=0.33, 
P<0.001). Next strongest came CVD (r=0.26, P<0.001) and cancer (r=0.23, 
P<0.001). The association was statistically significantly weaker for depression 
than any of the other diseases (r=0.19, P<0.001). Differences in the strength 
of correlation were statistically tested (Preacher, 2002) and considered 
significant when P<0.05. 
Correlations between perceived risks of different diseases were moderate 
(highest for CVD and diabetes, r=0.43, P<0.001) whereas correlations 
between family histories were weaker (highest for CVD and diabetes, r=0.17, 
P<0.001). Those whose BMI was higher perceived clearly higher risks of 
diabetes (r=0.34, P<0.001) and CVD (r=0.25, P<0.001), whereas health 
behaviour (physical activity, smoking, alcohol consumption) had weaker 
associations with perceived risks.  
In multivariate regression analyses (Table 2), associations between family 
history and perceived risk (step 1) did not change after adding 
sociodemographics (step 2: gender, age, education years) or BMI and health 
behaviours (step 3) to the model. DILGOM sub-sample was used to add 
depressive symptoms (step 4), this did not change associations between family 
history and perceived risk of diabetes, CVD, and cancer. Depressive symptoms 
 42 
did, however, have an effect on perceived risk of CVD (ǃ=0.13, P<0.001), 
diabetes (ǃ=0.16, P<0.001), and cancer (ǃ=0.14, P<0.001). 
Interaction analyses showed that, in general, health behaviours and BMI 
did not moderate the association of family history and perceived risk: only 3 
out of 16 tested interactions were statistically significant (P<0.05). For 
sociodemographics, 6 out of 12 tested interactions were statistically significant 
(P<0.05). Associations of family history and perceived risk tended to be 
slightly stronger among younger and more educated participants, and – for 
perceived risk of depression – among women. Depressive symptoms did not 
moderate associations between family history and perceived risks of somatic 
diseases. Details of the interaction analyses are described in article 1.
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Table 1. Descriptive characteristics of the FINRISK 2007 study sample (N=5744–6258). 
  
 
Mean (sd) or % Min-Max 
Women 53.1 %  
Age 50.8 (13.9) 25.0í74.0 
Education years 12.8 (4.0) 0.0í50.0 
Alcohol consymption (g/week) 76.4 (142.2) 0.0í1590.0 
    
Body Mass Index (kg/m2) 27.1 (4.9) 16.0í63.3 
 Normal weight 36.0 %  
 Overweight 40.4 %  
 Obese 22.8 %  
 
Smoking   
 Never smokers 53.9 %  
 Former smokers 25.3 %  
 Current smokers 20.3 %  
 
Physical activity   
 Sedentary 20.3 %  
 Moderately active 53.2 %  
 Active 26.0 %  
    
Family history ¹   
Early myocardial infarction 25.3 % 
 Diabetes 28.4 %  
 Cancer 36.7 %  
 Depression 19.6 %  
 
Perceived risk   
 Cardiovascular disease 2.8 (0.9) 1í5 
 Diabetes 2.4 (0.9) 1í5 
 Cancer 2.7 (0.8) 1í5 
 Depression 2.0 (0.9) 1í5 
    
Depressive symptoms ² 10.2 (7.5) 0.0í51.0 
¹ One or more affected first-degree relatives.  
² Subsample N=4913.   
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7.2 LONGITUDINAL ASSOCIATIONS OF PERCEIVED 
RISK AND RISK INDICATORS 
Sub-study II examined how perceived risk relates to behavioural and 
physiological risk indicators of diabetes and CVD over five years. Descriptive 
characteristics of sub-study II participants (FINRISK Blood Glucose Study 
2002) are presented in Table 3. Means of perceived risks were higher among 
the high diabetes risk sample, but between 2=low and 3=moderate among 
both samples at both measurement points. However, at follow-up a third of 
the high risk sample were diagnosed with diabetes. Mean levels of baseline 
self-efficacy to make healthy choices were moderate (slightly below 3=quite 
certain). Mean level of outcome beliefs about possibility to prevent chronic 
illness through lifestyle were quite high among both samples. 
In cross-lagged autoregressive models (for an example, see Figure 2), 
baseline perceived risk of diabetes did not predict physical activity, BMI, or 2-
hour glucose after five years. In contrast, higher perceived diabetes risk at 
follow-up was predicted by higher glucose (high risk sample ǃ=0.13, P<0.014), 
higher BMI (low/moderate risk sample ǃ=0.15, P<0.001), and higher physical 
activity (low/moderate risk sample ǃ=0.08, P=0.035) at baseline.  
Similar cross-lagged models of perceived CVD risk showed that perceived 
risk of CVD did not predict physical activity or BMI over five years. Again, 
higher baseline BMI predicted higher perceived CVD risk (low/moderate risk 
sample ǃ=0.10, P=0.006; high risk sample ǃ=0.09, P=0.037). Physical activity 
did not predict perceived CVD risk. Results from all cross-lagged models were 
similar among both high risk and low/moderate risk samples (¨ǒ²-values 
0.10–2.21, ¨df=1, P-values 0.137–0.752). 
  
 46 
Table 3. Descriptive characteristics of the FINRISK Blood Glucose Study 2002 participants. 
Baseline 2002 
Low/moderate risk 
sample N=451–477 
High diabetes risk 
sample N=390–432 
 
Min–Max 
Women % 57.7 56.9  
Age mean (sd) 55.9 (6.9) 59.3 (7.0) 45–74 
Body mass index (kg/m2) mean (sd) 27.1 (4.2) 30.3 (4.7) 18.8–45.6 
Body mass index  30, % 21.0 47.0  
Physical activity mean (sd) 2.5 (1.9) 2.4 (2.1) 0–14 
2-hour glucose mean (sd) 5.8 (1.1) 9.2 (3.1) 0.7–29.5 
    
Perceived diabetes risk mean (sd) 2.4 (0.9) 2.8 (0.9) 1–5 
Perceived cardiovascular disease risk mean (sd) 2.9 (0.9) 3.1 (0.9) 1–5 
Self-efficacy mean (sd) ¹ 2.8 (0.5) 2.7 (0.6) 1–4 
Outcome beliefs mean (sd) ² 11.3 (1.7) 11.2 (1.8) 5–14 
    
    
Follow-up 2007 N=437–477 N=416–432   
Women % 57.7 56.9  
Body mass index mean (sd) 27.0 (4.5) 30.2 (5.0) 17.7௅48.3 
Body mass index  30, % 21.9 47.1  
Physical activity mean (sd) 2.6 (1.5) 2.4 (1.6) 0–5 
2-hour glucose mean (sd) 6.3 (1.9) 8.7 (3.0) 2.4–25.8 
    
Perceived diabetes risk mean (sd) 2.4 (0.9) 3.0 (0.9) 1–5 
Perceived cardiovascular disease risk mean (sd) 2.8 (0.8) 3.0 (0.9) 1–5 
    
Glucose lowering medication % 0.6 11.1  
Onset of diabetes % 6.4 34.2  
¹ Available scale 1–4. 
² Available scale 3–14. 
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Figure 2 Unstandardized age- and gender-adjusted results from a cross-lagged 
autoregressive model (FINRISK Blood Glucose Study 2002). 
 
The combined measurement model of self-efficacy (six items) and outcome 
beliefs (three items) showed reasonable fit (Hu & Bentler, 1999) with the data 
in the low/moderate risk sample (ǒ²=153.99, df=26, P<0.001; CFI=0.910; 
TLI=0.845; RMSEA=0.102) and in the high risk sample (ǒ²=113.51, df=26, 
P<0.001; CFI=0.935; TLI=0.887; RMSEA=0.088). Standardized factor 
loadings were highly similar among the low/average risk sample and the high 
risk sample (0.55–0.80 for self-efficacy, 0.33–0.69 for outcome beliefs, all P-
values<0.001). Latent factors self-efficacy and outcome beliefs had a 
moderate, positive correlation in the low/moderate (r=0.28, P=0.001) and in 
the high risk (r=0.41, P<0.001) sample. 
Further SEM models included perceived risk of diabetes/CVD, self-
efficacy, and outcome beliefs (2002) as predictors of physical activity, BMI, 
and 2-hour glucose (2007). All models were adjusted for gender, age, and 
baseline level of outcome variable. Those who had a higher self-efficacy at 
baseline increased physical activity at follow-up (standardized ǃ-values 
between 0.11–0.18, P-values 0.007–0.034). However, self-efficacy did not 
predict BMI or 2-hour glucose. Perceived risks of diabetes and CVD did not 
predict physical activity, BMI, or 2-hour glucose; nor did outcome beliefs.  
In sum, the quantitative sub-studies showed that family history was related 
to perceived risk across different diseases, but perceived risk did not predict 
health promoting changes in behavioural or physiological risk indicators over 
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five years. Next sections describe results of the qualitative studies, which 
explored perspectives on receiving new risk information: secondary findings 
from genome sequencing. 
7.3 NEEDS AND CONCERNS AROUND SECONDARY 
FINDINGS 
Since the study scenario of the qualitative inquiry described a situation in 
which participants had already given their consent to receiving secondary 
findings, the focus group discussion mostly focused on the aftermath of 
receiving secondary findings, instead of consent procedures. Overall, 
participants thought reporting secondary findings for actionable diseases was 
acceptable and useful. Mixed feelings were also expressed, particularly 
towards the end of discussions. Mixed feelings seemed to arise when 
participants had had time to thoroughly elaborate complexities of the matter: 
magnitudes of risks, efficiency of treatment, consequences to social relations 
and individual identities. 
In the midst of the discussions, participants were presented with a brief 
slide show that contained more information about the two diseases under 
discussion. Course of discussion did not remarkably change after receiving 
more information, but participants pointed out that the letters could contain 
some more information on the disease prevention, to avoid 
misunderstandings, distress, and avoidant reactions.  
Five major themes were identified: immediate shock, dealing with worry 
and heightened risk, fear of being left alone to deal with secondary findings, 
disclosing to family and support needs.  
 
Immediate shock 
First reaction to the vignette letter was negotiating how shocking this 
information was. Some described the letter as a ‘surprise’ or ‘bomb’, whereas 
a minority stated the opposite: they ‘did not take it very seriously’ (D1=first 
speaker of focus group D). Some also pointed out that secondary findings 
could be a useful ‘wakeup call’, and remind one to ‘live one’s life to the fullest’ 
(A6). Participants also emphasized that individuals have different tendencies 
to worry; young people, females and those with an anxious personality were 
considered more likely to get upset upon receiving secondary findings. It was 
evident that it was not socially acceptable to belong to this vague group of 
people who would get too upset and ‘stick their head in the sand’ (D3). Parallel 
to negotiations about how shocking the secondary findings were, the 
acceptable level of worry was negotiated. Participants wanted to appear 
sensible and capable of coping: 
D2: but there are people who don’t need but the zero point zero something per cent 
risk and still the anxiety, the fear hits them and they collapse, you know that kind of 
people 
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D3: on my part I certainly would think about the odds  
D2: but that indicates courage. Then there are those who start to be fearful straight 
away before there is really anything at all 
D3: yeah, but I just wanted to make clear, that I would not like push it away, like 
because of fear, but instead like through reason 
 
Hence, in addition to dealing with the shock of receiving secondary findings, 
participants needed to deal with an implicit social pressure to cope with it.  
 
Dealing with worry and heightened risk 
Participants recognized that after receiving secondary findings, dealing with 
the information would continue after the immediate shock. They expressed 
concerns that knowledge of risk could threaten quality of life and holistic well-
being, or even evoke a self-fulfilling prophecy and trigger the illness to occur 
through ‘stress’, ‘placebo effect’, or ‘energy’: 
A6: if we learn about a possibility to develop some illness, and then we give it 
both our own energy and our relatives’ worry energy, and start to like dwell 
on it (--) so are you like actively activating the gene 
 
Too vigorous attempts to control one’s health were disapproved, similarly as 
too emotional first reactions (described above): 
A7: everything has to be so controlled (--) and then you just hysterically follow 
[guidelines of authorities] (--) like common sense is all lost [these days] 
 
Altogether, receiving secondary findings was seen as to require immediate as 
well as long term coping with distress. This potential distress was amplified as 
participants were concerned whether they would be left on their own to deal 
with it. 
 
Fear of being left alone to deal with secondary findings 
Focus group participants emphasized that immediately after receiving 
secondary findings, support via phone or personal contact should be easily 
available. They also brought up that individual life situations would likely 
contribute to how much support would be needed. Young people were, again, 
seen as more vulnerable, as risk information could affect their life choises or 
isolate them from their peers: 
D2: how on earth would a [15-year-old] person who wants to be like everyone 
else bear having this kind of very rare thing [risk for LFS], so it would be even 
worse, at a certain age 
 
In contrast, at an older age, threat of illness would be more commonplace and 
not so threatening to social relations. 
Concerns of being left alone to deal with secondary findings were 
contextualized within the Finnish healthcare system and society in general. 
Participants explicitly pointed out that reporting secondary findings would be 
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more acceptable in equal, just societies with a well-functioning healthcare 
system: 
A7: we have exceedingly skilled clinical professionals, and our doctors and 
research and everything are really top-notch, like the care one receives in 
Finland is so good so I definitely wouldn’t be worried one bit 
 
It was argued that in a society where not everyone has access to relevant 
treatment and care, reporting secondary findings could benefit the well-off 
and harm the disadvantaged: 
B1: if the society is like just and equal, then people might be more ready to 
receive the [secondary finding] information, because they would feel they are 
safe (pause) but if it’s a very unequal society, and everything is like going in a 
bad way (pause) then it could be, it’s hard to say, then everyone acts more 
(pause) from their own stances. Some flush their lives down the toilet and 
some [other interviewee: pull themselves together] yeah, pull themselves 
together 
 
Worry about being left alone to deal with secondary findings was also linked 
to concerns about how this information should be communicated to family 
members.  
 
Disclosing to family 
Disclosing secondary findings was seen as a difficult task even for 
professionals. Hence, participants were concerned how they would be able to 
disclose this information to their family, and whether there would be support 
available for this. Participants expressed concerns about their family 
members’ health but also how disclosing such information might affect family 
relations. Participants felt responsible to disclose but also to protect their 
relatives, particularly children, from worry.  
C4: you really have no answers to questions that could arise in that situation, 
so it would be quite a scary situation, I mean informing others, how to then 
do it so that the other one doesn’t panic altogether 
 
Consequently, when thinking of disclosing secondary findings to others, one 
no longer was in the position of needing support, but in the position of the one 
who has the responsibility to provide support.  
 
Support needs: information, access to care, empathetic 
communication 
Three types of intertwined support needs to tackle concerns described above 
were identified. Participants emphasized that after receiving secondary 
findings, access to reliable and reassuring information about the disease risk 
and its implication would be crucial for coping, since ‘these days you can find 
all kinds of [scary and unreliable] things on the internet’ (D1). Information 
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about preventive and treatment methods would help to gain control over the 
situation. 
A5: at first you panic, but the more you get to know about the matter, the 
easier it gets. And then if you know, like (pause) how it’s treated. To me that’s 
always the most important, that I know how to go forward, and how I can 
survive this (pause) so, I think this letter is very good. And the fact that you 
can contact, probably I would contact them (pause) so (pause) I would like to 
discuss it further with an expert  
 
Similarly to participants A5 above, many participants pointed out that a 
personal contact with an expert would be important. However, participants 
also strongly expressed concerns that not all professionals might be able to 
provide this information in the right way. The right way would be empathetic 
communication.  
D4: it has an enormous impact, what kind of (pause) conversation you can 
create then, and plan for further care, that gets you through everything 
 
Need for information was intertwined with an emotional need to be taken care 
of and treated in a respectful manner. This would promote feelings of safety 
and being valued. 
7.4 TYPE OF DISEASE MATTERS WHEN RECEIVING 
SECONDARY FINDINGS 
Sub-study IV focused on meanings of different diseases in the context of 
secondary findings. In addition to focus group data, the study included 
immediate written reactions to vignette letters. First reactions varied from 
neutral or grateful to terrified, angry, or regret over consenting to receive 
secondary findings. The major themes were familiarity, severity in terms of 
lived experience, cancer vs. heart disease, somatic vs. psychiatric disease, 
access to treatment, stigma, and responsibility. To protect anonymity of 
written reactions, they are referred to by participant numbers (P1–P29), and 
focus group comments similarly as above (A1=first speaker of focus group A). 
 
Interplay of familiarity and severity of disease 
Individual earlier experiences and familiarity of the disease strongly shaped 
first reactions. The power of previous experiences was clearly demonstrated 
by the written reaction to the LS letter of a participant whose father had died 
from colorectal cancer: ‘I’m terrified (--) I will call the hospital immediately 
for further instructions (--) I don’t want the same destiny (--) I would die 
slowly too’ (P4). 
Comparing reactions to the four diseases at focus is extremely tentative, 
since individual reactions varied greatly. However, reactions to FH tended to 
be brief and neutral: ‘I would act according to the recommendations in the 
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letter’ (P20). The letter for LQTS evoked questions about what the disease is 
like: ‘I would be frightened at first and wonder what this information really 
means for my own and my possible child’s life’ (P23). Shock upon the LS letter 
was alleviated by the preventive method that were mentioned: ‘Sure the 
information would be overwhelming for a moment (--) I would find out about 
the treatment/prevention possibilities as much as I can and start trying those’ 
(P1). Written reactions to the LFS letter were lengthier and more emotional. 
‘Maybe I shouldn’t have signed the consent for contact. First feeling is despair, 
in particular if I have children at this point, I mean worry for children’ (P10).  
 
Cancer vs. heart disease 
Earlier experiences and knowledge about diseases influenced not only written 
first reactions but also further elaborations during the focus group 
discussions. Overall, cancer related letters were considered more threatening 
compared to cardiovascular related letters: 
B2: my heart would’ve probably been racing more if I had read this cancer 
thing. In my opinion everybody has cholesterol, and it’s not fatal straight 
away, so I think these [letters] are on a completely different level 
 
D1: I somehow, indeed, well I didn’t take very seriously that disease [LQTS] 
(laughs) I just read it and like ‘so what’. So if I had received this cancer letter 
[LFS] I might have responded differently. Cancer as a word is worse straight 
away, it takes you aback in itself. 
 
However, participants commented that cancer related findings would still be 
less distressing than genetic risk information for psychiatric disorders. 
 
Somatic vs. psychiatric disease 
Unexpectedly, three out of four focus groups pointed out that receiving genetic 
risk information for psychiatric (e.g. schizophrenia, bipolar disorder) or 
incurable neurological disorders (Alzheimer’s disease), alcoholism, or 
intellectual disability of children would be more distressing compared to the 
somatic diseases described in the vignette letters. They outlined several 
reasons for this. Overall, psychiatric and somatic diseases were differentiated 
in four ways. Psychiatric disorders were perceived more burdensome in their 
1) severity in terms of lived experience of disease, 2) treatability and access to 
treatment, 3) level of stigma, and 4) individual’s responsibility for managing 
the risk. 
Participants said that living with psychiatric disorders and Alzheimer’s 
disease is very hard for individuals and families. This is why the idea of 
receiving such risk information was distressing. 
A4: I would rather have [my children] with a physical illness [A2: So would 
I], because life is pretty horrible with those fears and delusions 
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Access to treatment 
Psychiatric risks were also seen as hard to live with because participants 
perceived it is hard to get efficient early psychiatric treatment.  
A7: if I have a (pause) some kind of physical illness, they won’t tell me that 
‘Well let’s wait until you rot, then we will take you in for treatment’ but they 
will start to examine [A2: Yeah] based on first symptoms to find out what it 
could be and as soon as possible start medication and treatment so that it will 
not get worse [A2: It’s about attitudes] but for psychiatric illnesses it’s 
completely the other way around 
 
With poor access to treatment, individuals were implicitly regarded as more 
responsible for managing psychiatric risks on their own. This contributed to 
implicitly blaming individuals for their psychiatric problems and increasing 
their stigma. 
 
Stigma and responsibility 
Psychiatric disorders were seen as more stigmatized than somatic diseases: 
‘stigma is thrown upon the whole family [when psychiatric disorder occurs]’ 
(A2).  
In a more implicit manner, it was evident that perceptions of 
responsibilities of individuals and health care system influenced how 
participants made sense of potentially receiving genetic risk information for 
psychiatric disorders. Knowledge of risk could be seen as a burden or a relief. 
Treatment of somatic diseases was seen as the responsibility of the healthcare 
system, more so that treatment of psychiatric disorders. This was partly 
because early psychiatric treatment was seen as scarcely available as described 
above: individuals need to take responsibility if the health care does not do it. 
In addition, the nature of psychiatric diseases played a role in these 
perceptions. Since psychiatric disorders or alcoholism tend to show observable 
early symptoms, individuals were seen as responsible to monitor and cope 
with these symptoms. Knowledge of genetic risk could increase control over 
the risk but also pose the individual additional burdensome responsibility.  
A7: I think also with mental health problems [similar to alcoholism] (--) I can 
pretty well analyze my own behavior after all (--) Say for example if you have 
depression in your family. (--) But for this type of physical illnesses, you can’t, 
if they show no symptoms, you can’t do anything [to monitor it] 
 
B1: when you know there is a hereditary risk for depression in your family (-
-) then you can start to, build your life or your lifestyle, take it into account, 
like for example ‘I have to avoid extreme stress, because stress predisposes to 
depression’ (--) or hereditary susceptibility to alcoholism, also then, when the 
person knows it, they can influence, so that it is perhaps best to stay away 
from using alcohol completely 
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In contrast, individuals were not allocated a same level of responsibility in 
preventing somatic diseases even when their onset could be influenced by 
healthy lifestyle: 
B3: suddenly life turns around, there comes an uninvited guest [=somatic 
disease] (pause) [--] we can’t that well, we can’t like earn a good life ourselves 
cause, cause verifiably people die of for example some horrible disease, even 
if they look so healthy and have lived so healthily, cause nothing is hundred 
percent certain 
 
In sum, level of stigma, access to treatment and nature of the disease itself 
shaped how burdensome receiving genetic risk information would be.  
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 DISCUSSION 
The quantitative part of this study found that family history contributed to 
perceived risks of common diseases independently of sociodemographics, 
BMI, health behaviour, or depressive symptoms (sub-study I). Family history 
contributed to perceived risk more strongly for somatic diseases – diabetes, 
CVD, and cancer – compared to depression. Over a five-year follow-up (sub-
study II), however, perceived risk of diabetes or CVD at baseline did not 
predict health-promoting changes in physical activity, BMI, or blood glucose 
level. This was observed similarly among two samples with a different diabetes 
risk status who received individual biomarker risk feedback after study 
baseline. On the contrary, baseline risk indicators predicted slightly higher 
perceived disease risks after five years. Self-efficacy predicted slightly 
increased physical activity over five years, but outcome beliefs did not predict 
physical activity, BMI, or blood glucose. 
The qualitative part of this study revealed that even when people think 
returning secondary findings from genome sequencing is useful and 
acceptable, they may worry about whether counseling or relevant surveillance 
and preventive care are available for individuals and families (sub-study III). 
The results underline the importance of taking into account the societal 
context, including different health care systems, when evaluating acceptability 
of secondary findings reporting practices. The results also suggest that genetic 
risk information may be more threatening when it concerns cancer compared 
to heart-related conditions, but genetic risk information for psychiatric 
disorders could provoke even more distress (sub-study IV). Lay perceptions of 
disease severity and treatability may be heuristic and possibly not always in 
line with expert knowledge on specific diseases and their treatment 
possibilities. 
In this section I will first focus on elaborating results on risk perception and 
health behaviour, and then continue to discuss the results on secondary 
findings. In the end, I will reflect on the methodology, and present my 
concluding remarks. 
8.1 RISK PERCEPTION AND HEALTH BEHAVIOUR 
Perceived risk of disease is expected to reflect actual risk factors, but also 
general cognitive tendencies. Indeed, perceived risks of different diseases were 
related to each other (sub-study I), as in previous research (DiLorenzo et al., 
2006). In line with literature on unrealistic optimism (Weinstein & Klein, 
1996), this study found that people tend to underestimate their risk: on 
average, those at high diabetes risk perceived their lifetime risk as moderate, 
but after five years a third of them already had diabetes (sub-study II). On the 
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other hand, sub-study I found that those who have depressive symptoms may 
be less optimistically biased since their risk perceptions tended to be higher. 
However, this pessimism seemed not to translate into genetic fatalism: one 
might expect that family history would contribute to perceived risk more 
strongly among those with depressive symptoms, but this was not supported 
by the data (sub-study I).  
It is noteworthy that tendency to perceive risks was also discussed by the 
focus group participants of the qualitative inquiry. While individual 
responsibility for taking care of one’s health was emphasized, tendency to 
worry in general was depicted as an undesirable personality characteristic. 
Optimistic risk perceptions could also partly reflect social norms according to 
which tendency to perceive risks is not a desirable characteristic. Some focus 
group participants explicitly linked tendency to worry with females, and this 
can be seen as stereotypical but also ‘accurate’, since women and 
disadvantaged ethnic minorities do tend to perceive higher risks in various life 
domains, compared to white males (Kahan, Braman, Gastil, Slovic, & Mertz, 
2007). These observations show that risk perception is not simply rational 
calculation, but interacts with one’s personal life in nuanced ways. 
In the cross-sectional setting of sub-study I, family history was related to 
perceived risk across different multifactorial diseases: diabetes, CVD, cancer, 
and depression. This is in line with previous studies on risk perceptions of 
somatic diseases (DiLorenzo et al., 2006), and an earlier Finnish survey 
(Jallinoja & Aro, 1999), where diabetes and CVD were most frequently 
mentioned when participants were asked to name diseases that are hereditary. 
The population based data of this study showed that the relationship of family 
history and perceived risk was robust and did not change after accounting for 
sociodemographics and several health behaviours, BMI, and depressive 
symptoms, which could reflect a more pessimistic cognitive tendency. 
Furthermore, the large data made it possible to test interactive effects of family 
history and other factors in relation to perceived risk. Health behaviour and 
family history showed no systematic interactive effects on perceived risks. 
These findings support previous research, which suggests that lay people 
consider genetic and behavioural risk factors as adding to each other (Condit 
& Shen, 2011), meaning that people tend not to focus on the interactive nature 
of genes and health behaviour. Among younger and more educated people, 
however, family history tended to contribute to perceived risks slightly more 
strongly than among older and less educated people. Younger and more 
educated people are likely to be more aware of heritability of common 
diseases, since they have more knowledge about genetics (Haukkala et al., 
2018; Jallinoja & Aro, 1999). 
A new contribution of this study was that the association of family history 
and perceived risk was also observed for a psychiatric disorder, depression, at 
the population level. The association was weaker compared to somatic 
diseases. This could be related to measurement: perceived risk concerned only 
severe depression, and family history concerned only diagnosed depression. 
 57 
People could often be unaware whether their family member had been 
diagnosed, even if the family member would show observable depressive 
symptoms. However, environmental risk factors for depression may be better 
known among the public, compared to hereditary risk for depression (Jorm et 
al., 1997). The qualitative results of the current study also suggest that 
possibility to monitor early psychiatric symptoms shapes how individuals 
evaluate their risks, which could result in less emphasis on their family history, 
compared to somatic diseases. More research is needed on how perceptions of 
causes of psychiatric disorders contribute to how individuals manage these 
risks. 
The qualitative results of sub-study IV revealed that genetic risk 
information on psychiatric disorders could be more distressing compared to 
risks of common somatic diseases. This was an unexpected finding, as the 
vignettes and interview guide did not concern psychiatric risks. Reasons 
behind distress over psychiatric risks seemed to include potential stigma but 
also perceptions that early access to treatment is poorer for psychiatric 
compared to somatic diseases. What seemed to follow partly from poor access 
to treatment and partly from possibility to monitor early psychiatric symptoms 
was that individuals were seen to be left with more responsibility for managing 
psychiatric risks, whereas the public health care was seen to take more 
responsibility for somatic risks. Also previous literature has raised concerns 
that psychiatric genetic risks could potentially be more stigmatizing (Bunnik 
et al., 2012; Kostick et al., 2018), but the current study highlights that this may 
not only relate to the nature of illness itself but also to how treatment of 
different disorders is organized in different healthcare contexts. 
This study also looked at bi-directionality of perceived risk and risk 
indicators in a longitudinal setting. The study results provided some support 
for accuracy hypothesis but not the behavioural motivation hypothesis of risk 
perception (Weinstein & Nicolich, 1993). People at high diabetes risk 
underestimated their risk, but nevertheless risk perceptions reflected 
behavioural and physiological risk indicators. During a five-year follow-up, 
however, perceived risk did nor predict health promoting changes in physical 
activity, body weight, or blood glucose. It should be noted that in the 
longitudinal setting of sub-study II, perceived risks of diseases were measured 
before and not right after participants received health examination based 
biomarker feedback. Biomarker feedback may have temporarily changed risk 
perceptions and behavioural intentions (McClure, 2002), but these could not 
be assessed in this study. Health examination based feedback is part of the 
FINRISK study protocol, but participants have only been asked to fill in 
questionnaires before health examination. If the biomarker feedback 
encouraged intentions to make lifestyle changes, it is possible that these were 
not accomplished in the longer term. These results stress that to accomplish 
sustained changes in weekly physical activity or weight, risk perception or 
biomarker feedback alone is likely to be inefficient. To encourage preventive 
intention, risk information should ideally be combined with counselling and 
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repeated measurements of risk indicators (Sheridan et al., 2010). Behaviour 
change techniques such as promoting goal setting and monitoring one’s 
behaviour seem to make successful changes in physical activity and healthy 
eating (Michie, Abraham, Whittington, McAteer, & Gupta, 2009). The 
qualitative results of this study support the perspective of counselling, since 
focus group participants wished that when secondary findings indicating risk 
for disease are communicated, this should be combined with counselling and 
practical advice on how to reduce risk. Similar wishes for practical plans have 
been observed also in other qualitative studies on receipt of secondary findings 
(Daack-Hirsch et al., 2013). 
In addition to risk perception, other social cognitive determinants need to 
be considered when aiming to prevent chronic diseases, as suggested by e.g. 
the HAPA model (Schwarzer, 2008). Similar to numerous previous studies 
(Gholami et al., 2014; Teixeira et al., 2015; Zhang et al., 2018), the current 
study showed that self-efficacy matters in health behaviour change. Self-
efficacy predicted increased physical activity over five years (sub-study II). In 
contrast to previous research, however, outcome beliefs did not predict health 
promoting changes, but this may be explained by weakness of the used 
measure: only three items were included in the outcome beliefs latent factor, 
and factor loadings were only moderate. Overall, the current study results 
support previous studies’ conclusions that risk perception alone is unlikely to 
lead to sustained health behaviour changes. This was observed similarly 
among those with a high diabetes risk and those with a low or moderate risk. 
Interventions need to target risk perceptions together with other social 
cognitive factors (Harvey & Lawson, 2009; Rimal, 2001; Sheeran et al., 2014). 
Finally, we need to keep in mind that risk perception is expected to predict 
protective behaviour. Risk perception seems to have the strongest effect on 
behaviours whose consequences mostly concern health (Wright, 2010). 
Physical activity and eating carry a complex set of meanings in people’s lives; 
these behaviours are a lot more than means to prevent disease. This is likely to 
weaken the effect of perceived risks on such complex behaviours. 
Perceptions of risks and different diseases serve as a context for receipt of 
new risk information. As an example of this, the qualitative inquiry of this 
study focused on the situation of receiving secondary findings from genome 
sequencing. 
 
8.2 LAY PERSPECTIVES ON GENETIC RISKS 
The theoretical perspective of illness representations (Hagger & Orbell, 2003; 
Leventhal et al., 1980) was identified as a useful perspective for making sense 
of how individuals approach new genetic risk information. The qualitative 
results of this study provided insight into detailed ways in which familiarity of 
disease plays a role when interpreting genetic risk information (sub-study IV). 
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Family history of disease not only provides information on personal risk but 
also most likely contributes to illness representations. Having had an illness 
in the family may provide tangible first-hand experience of the lived 
experience, the consequences of a disease, as proposed by the Common Sense 
Model of illness representations (Leventhal et al., 1980). In case one has no 
experience of the illness whose risk is communicated, one uses their 
experience and knowledge of illnesses that are somehow similar: focus group 
participants used their overall understandings of cancer when making sense 
of unfamiliar heritable cancer syndromes. Illness representations may be 
generalized, for example so that the word ‘cancer’ evokes vivid emotional 
representations of the familiar illness, even when one rationalizes that types 
of cancers vary, as the focus group data of this study suggested. As a result, lay 
illness representations and illness categories may be different to those of 
professionals.  
The qualitative results showed that categories of ‘multifactorial diseases’ 
and ‘heritable diseases’ that are somewhat clear-cut for professionals, might 
be less so for lay people. While professionals may use categories such as 
‘actionable heritable diseases’, ‘non-actionable heritable diseases’, ‘ carrier 
status for recessive heritable diseases’, and ‘multifactorial diseases’, lay people 
could be more in terms with categories such as ‘somatic diseases’ and 
‘psychiatric diseases’, or ‘cancer’ and ‘heart disease’. These perspectives are 
not contradictory, but they provide different points of views for interpreting 
meanings of genetic risk information. Experts make a clear distinction 
between polygenic risk scores for multifactorial diseases and single variants 
indicating high risks for heritable diseases, but lay people may approach 
genetic risk information primarily from the point of view of disease type, 
instead of magnitude of risk or mode of inheritance (Bacon et al., 2015). 
Differences in professional and lay ways of categorizing diseases can be 
understood from the perspective of the Common Sense Model of illness 
representations (Hagger & Orbell, 2003; Leventhal et al., 1980). Whereas 
health professionals may emphasize the cause and control dimensions since 
they focus on prevention and treatment of the illness, lay people may put more 
emphasis on, for example, the consequences dimension since they evaluate 
how living with the illness would be like as an experience. Also previous 
qualitative research has shown that even when lay and expert understandings 
of diseases match well, long-term consequences seem to be a more dominant 
aspect of lay illness representations compared to expert conceptualizations of 
diseases such as CVD and diabetes (Damman & Timmermans, 2012).  
Consequences could also be related to personal identity (Viberg, Segerdahl, 
Hösterey Ugander, Hansson, & Langenskiöld, 2018), which is why potentially 
stigmatizing information could be threatening irrespective of the health 
implications. Focus group participants of this study considered 
communicating risks to younger people as more problematic, since they 
considered it could have a stronger impact on their social relations and life 
choices at that point. Similarly to focus group participants of this study, 
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genetic experts have pointed out that receipt of psychiatric genetic risk 
information could be more harmful than risks for somatic diseases (Kostick et 
al., 2018). A recent study among psychiatric genetic researchers  (Kostick et 
al., 2018) shows that some experts view that knowledge of actionable 
psychiatric risks should be available for people, similarly as actionable somatic 
risk information. Still, experts hesitate how to balance between protecting 
psychiatric patients from distress, and not being too paternalistic. As a 
consequence, currently only a minority of experts consistently communicate 
psychiatric genetic risks to patients (Kostick et al., 2018). The current study 
adds to this discussion the point of view that responsibilities for managing 
psychiatric and somatic risks may be seen differently allocated, and this could 
contribute to potential distress of receiving risk information for different types 
of diseases. Since participants perceived that access to care is better for 
somatic diseases compared to psychiatric diseases, receiving psychiatric risk 
information was seen to impose stronger responsibility for the individual to 
manage such risks. Hence, psychiatric risk information seemed more 
distressing also because how psychiatric treatment is organised, not only 
because of the nature of illness per se. 
The dimension of illness identity as proposed by the CSM (Leventhal et al., 
1980) may be useful for understanding processing of risk information. Identity 
refers to the label of the illness and its characteristic symptoms (Hagger & 
Orbell, 2003); an illness with a clear label and symptoms that make sense is 
perceived as a more coherent whole than an an illness without clear symptoms. 
In a previous quantitative assessment among families with LS or BRCA 
mutations predisposing to breast and ovarian cancers, perception that the 
illness is ambiguous and does not make sense as a whole was associated with 
higher distress six months after predictive genetic testing for cancer (van 
Oostrom et al., 2007b). In contrast, other studies have linked coherent illness 
identity with higher distress (Hagger & Orbell, 2003), but this could be 
because illness identity is often measured as presence of symptoms. In the 
current study, perceived ambiguity of LQTS provoked some distress. On the 
other hand, FH tended to be paralleled with high cholesterol and hence as a 
risk factor, not as an illness in itself, and therefore less threatening, althout it 
is a serious condition if untreated (Youngblom et al., 1993). Cancer was 
perceived as a clear entity but still distressing because of severe consequences. 
More research is needed on how coherence of illness identity interacts with 
other dimensions of illness represenations, particularly in contexts of genetic 
risks and variants of unknown significance. Similarly as a disease, also a 
certain risk variant may have a clear identity and implications, or a vague 
identity and unclear implications, which could induce more distress over the 
uncertainty (Solomon et al., 2017). 
Focus group data of this study showed that dimensions of illness 
representations could be applied not only to the illness but also to the risk of 
illness. The data showed that knowledge of risk extends the perceived timeline 
of the disease. The start of the illness could be at the time of first symptoms or 
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diagnosis, but receiving risk information seemed to be perceived as the 
starting point for living with the potential illness. Receiving genetic risk 
information will have consequences for one’s life even before illness occurs. 
Potential worry and preventive medications or screenings were perceived to 
potentially affect quality of life as a whole. In a way, recipients of risk 
information become ‘pre-patients’. Lay people may not always clearly 
distinguish being at risk from being ill (Damman & Timmermans, 2012). 
Instead, being ‘at risk’ can be experienced as a liminal state between being 
healthy and being ill (Scott, Prior, Wood, & Gray, 2005).  
Understanding implications of being ‘at risk’ sheds light on why people 
might decline genetic testing even when it would be ‘rational’ from the 
perspective of disease prevention. For example, representations of what it 
means to be ‘at risk’ could contribute to choosing not to proceed with or 
procrastinating with genetic testing for heritable diseases such as Lynch 
syndrome, which has efficient preventive possibilities (Jarvinen et al., 2009). 
Previous studies have raised questions why a considerable proportion of 
individuals who have Lynch syndrome in their family have not proceeded with 
genetic testing (Aktan-Collan et al., 2011; Seppälä, Pylvänäinen, & Mecklin, 
2017). Whereas from the expert perspective it would be sensible to get tested 
for Lynch syndrome and attend surveillance if needes, from the lay perspective 
the step of taking the test may carry more meaning for one’s identity: a shift 
from being a ‘healthy person’ to being ‘at risk’.  
Psychological implications of being ‘at risk’ are also important from the 
perspective of resources of healthcare systems. Focus group participants of the 
current study were concerned whether there would be preventive surveillance 
and treatment available, if they were to be defined as ‘at risk’. Previous 
qualitative studies have even reported that people may be disappointed if 
genetic testing reveals they are not at high risk, because they may still perceive 
high risk based on their family history, but then they will not have access to 
services and may feel abandoned (Scott et al., 2005). If people are informed 
about their health risks, they may seek reassurance from surveillance 
(Parsons, Beale, Bennett, Jones, & Lycett, 2000). These perspectives need to 
be considered when formulating new practices in the field of genomics. If 
people are told they are ‘at risk’ they may perceive they are not healthy. To 
support public trust towards the healthcare and research, attention needs to 
be paid to resources for counselling and preventive treatment when 
communicating genetic risks.  
Overall, the qualitative results of this study highlight that it is important to 
consider the wider context of the healthcare system in different countries 
when forming practices of reporting genetic risks. Participants of the 
qualitative study worried about whether preventive treatment would be 
available after receipt of secondary findings (sub-study III). These findings 
support previous research results that highlight the importance of treatment 
plans (Daack-Hirsch et al., 2013) and timely access to re-testing (Haukkala et 
al., 2013).  
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The worry for clear treatment paths of the current qualitative inquiry may 
be partly explained by the current context of Finnish public healthcare. Public 
perception of efficiency and equality of healthcare in Finland are among the 
highest in Europe (Schneider & Popic, 2018), but a large reform of the public 
healthcare and social welfare services has been under preparation for several 
years. The reform was only once explicitly mentioned during the focus groups, 
but the complexity and uncertainties of this reform may have contributed to 
focus group participants’ worry about how preventive treatment would be 
organised, and whether access to it would be equal for everyone. Even though 
ethical principles of informed consent, promoting well-being and avoiding 
harm apply similarly everywhere, it needs to be acknowledged that practices 
of communicating genetic risks happen within existing relationships between 
individuals and institutions. These relationships form the context to risk 
communication practices. Trust towards healthcare and research is essential 
to achieve successful practices, but carelessly formed practices could also 
damage public trust towards healthcare and scientific research. Ethical 
discussion around communicating genetic risks needs not only to go on 
around consent practices but also on practices of referral to preventive 
treatment for individuals and families. 
 
8.3 METHODOLOGICAL CONSIDERATIONS 
This study combined quantitative and qualitative methods to gain overall 
understanding of risk perceptions and a nuanced understanding of how people 
process new risk information. The different approaches complemented each 
other (Johnson et al., 2007). Since the quantitative and qualitative sub-studies 
focused on somewhat different questions and diseases, it was not plausible to 
triangulate the quantitative and qualitative data during the analysis process. 
However, variation of methods came useful when interpreting the study 
results. Results of the qualitative studies provided additional insight into the 
more detailed ways in which people evaluate their personal risks for various 
types of diseases. The study was conducted in a Nordic society with a public 
healthcare system and a highly educated population (Official Statistics of 
Finland, 2017), and the results may not be applicable in societies that greatly 
differ in these respects. 
The quantitative studies used comprehensive Finnish population based 
survey and health examination data and allowed both cross-sectional and 
longitudinal assessments. The data was large enough for examining interactive 
effects of family history and other factors in relation to perceived risk. 
However, participants of FINRISK studies (sub-studies I and II) have a lower 
mortality rate compared to non-participants (Harald, Salomaa, Jousilahti, 
Koskinen, & Vartiainen, 2007), and participants of the qualitative studies were 
self-selected. Hence, the study was likely to include people who are healthier 
 63 
and more interested in health compared to the population average. In addition 
to this, the qualitative studies included few males, who may hold lower risk 
perceptions and process risk information differently compared to females 
(Kahan et al., 2007). Despite these limitations, the quantitative data allowed 
comparing different risk groups, and the qualitative study sample was diverse 
in terms of age, professions, and educational level. 
A strength of this study was that it was able to include both cross-sectional 
and longitudinal data on risk perception and risk factors, and thus provided 
the possibility to examine whether risk perception rather follows risk 
indicators or predicts health behaviour changes (Weinstein & Nicolich, 1993). 
The cross-sectional data showed that risk perceptions and risk factors are 
related to each other, and longitudinal data showed that perceived risk of 
chronic diseases did not lead to health promoting changes in behavioural or 
physiological risk indicators. However, it should be noted that conditioned risk 
perceptions (Brewer et al., 2007) were not assessed in this study. The 
questionnaires did not ask whether participants based their risk perceptions 
according to their current health behaviours, or whether they took into 
account their possible intentions to change their health behaviour for better or 
for worse. The measure of perceived risk captured perceived likelihood of 
developing the disease in question during one’s lifetime; perceived severity of 
disease was not assessed. The qualitative data showed that perceptions of 
disease severity did shape reactions to risk information and coping intentions. 
Including perceived severity of disease in quantitative studies could help to 
gain a more nuanced understanding of risk perception and health behaviour. 
Weakness of some of the non-validated self-reported measures used in sub-
study II – physical activity, self-efficacy, and outcome beliefs – may have 
resulted in conservative study results. Still, the study sample was large enough 
for using the statistical method structural equation modelling, which 
strengthened the study, as it helps to take into account covariation of multiple 
predictors and the effect of measurement error, and the method allows 
multiple-group analyses (Lomax & Schumacker, 2004). 
The qualitative inquiry could be criticised for the use of hypothetical 
scenarios, since people’s evaluations in imagined situations may not match 
how they think and act in a real life situation (Persky, Kaphingst, Condit, & 
McBride, 2007). However, with this approach it was possible to interview the 
participants immediately after they hypothetically had received secondary 
findings. In the midst of the possible shock of real life secondary findings, it 
might not be possible to conduct similar group interviews. Using this 
methodology it was possible to capture immediate perspectives on the matter, 
which might not come up if interviews were conducted later, after people have 
had time to adjust to the situation. Individual interviews would have allowed 
gaining deeper understanding of how individuals process risk information in 
relation to their personal life. However, a strength of the focus group approach 
was that it revealed some ways in which the social context affected how worries 
about genetic risks are expressed (Hollander, 2004). Shock and worry tended 
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to be expressed in a more straightforward manner in the private, individual 
written accounts, whereas during focus group discussions, participants made 
efforts to appear rational and not too prone to worry, as that was seen as an 
undesirable characteristic. Worries may still be more easily expressed in 
female dominant groups (Hollander, 2004). Perspectives on risk information 
may differ by gender (Kahan et al., 2007), but few males took part in the 
qualitative inquiry. Similarly, social norms could shape how people respond to 
research inquiries on reactions to secondary findings, or how they express 
worries during clinical encounters. Those with negative reactions to genetic 
results might not directly express this, if such reactions are perceived socially 
undesirable. 
The number of study participants in the qualitative studies was quite small, 
and individual perspectives on the topic of secondary findings varied greatly. 
These limited the possibility to compare reactions to different types of 
secondary findings, which the method of empathy-based stories (Eskola, 
1998) could be used for. Any comparisons between reactions to different types 
of secondary findings need to be interpreted as tentative, also because the 
vignettes used were parallel in structure but varied slightly in terms of content 
and length. We aimed to make the vignette letters as realistic as possible and 
not too frightening, and this is why numerical risk estimates or severe 
consequenses of the diseases were not described in the vignettes but were only 
discussed later in the focus groups. The familial hypercholesterolemia letter 
provided somewhat more detailed description, to convey that the condition is 
different from mildly elevated cholesterol. Our study results supported these 
choices, as the participants still thought the cancer letters were considerably 
more distressing.  
In each focus group, one cancer syndrome and one cardiovascular 
condition were discussed simultaneously. This clearly encouraged 
comparisons between these broad disease categories, whereas the study 
design provided less possibilities to explore perspectives on different types of 
cancer syndromes or different types of cardiovascular conditions. A previous 
study simultaneously examined perspectives on genetic testing among 
families with Lynch syndrome and families with BRCA 1/2 mutations that are 
linked to breast and ovarian cancer (van Oostrom et al., 2007a). They found 
that people among families with Lynch syndrome had a more positive outlook 
on hereditary cancer, whereas people among families with BRCA had more 
distress and more passive coping styles. In the current study, more nuanced 
perspectives on various types of cancers or cardiovascular conditions might 
have been observed, had these been discussed during the same focus group 
sessions.  
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8.4 IMPLICATIONS FOR FUTURE RESEARCH AND 
PRACTICE 
Increased use of genomic sequencing is likely to have many implications for 
healthcare. Whereas many other risk indicators, such as health behaviour, 
body weight, or biomarkers can be modified through health behaviour changes 
or medications, genetic predispositions are stable, although their 
interpretations may change as knowledge of genomics accumulates. However, 
genomics aim to identify people at high disease risks more accurately than 
before, so that lifestyle interventions and preventive treatments may be 
targeted more efficiently. In addition to possibility to calculate polygenic risks 
scores for multifactorial diseases and detecting single high-risk variants, 
genome sequencing may reveal pharmacogenetic findings that indicate 
sensitivities to medicines, or carrier status of recessive heritable diseases. 
Considerable proportions of survey respondents (Haukkala et al., 2018; 
Vermeulen, Henneman, van El, & Cornel, 2013) express interest in various 
types of genomic information that could be used in disease prevention.  
The qualitative results of this study suggest that people may approach the 
topic of genetic risk information primarily from the point of view of familiar 
illnesses, and may not clearly distinguish between, for example, multifactorial 
and heritable forms of diseases. Future studies need to be designed to examine 
how people process qualitatively different types of genetic risk information, 
including polygenic risk scores, high risk single variants, and carrier status, 
and how the nature of disease interacts with this processing. The qualitative 
results of this study showed that people were particularly worried about risks 
for their children. Carrier status for recessive heritable diseases and dominant 
high risk variants are treated differently in genomic practices, but from the 
point of view of worry for children, these types of risk information may share 
many meanings for lay people.  
Both qualitative and quantitative results of this study indicate that lay 
perspectives on hereditary risk information vary according to disease type. In 
the quantitative assessment of study I, the association of family history and 
perceived risk was weaker for depression compared to somatic diseases. 
Further research is needed to conclude whether this is because people are less 
aware of hereditary predisposition for depression or psychiatric disorders 
more generally, or whether they stress environmental factors or current signs 
of psychiatric symptoms more when considering psychiatric risks. 
Unexpectedly, the inductive thematic analysis of the qualitative data of this 
study revealed that people may perceive psychiatric genetic risk information 
more distressing compared to genetic risk information for somatic diseases. 
At the same time, individuals were seen as responsible to monitor early 
psychiatric symptoms and find treatment on time. More research is needed on 
how perceptions of heritability of different types of diseases contribute to 
perceptions of responsibilities for managing risks and illness. Future studies 
need to explore more specifically, how lay people evaluate hereditary risks for 
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psychiatric diseases, and whether these evaluations translate into how they 
manage such risks; for example, whether perceptions of hereditary psychiatric 
risks contribute to treatment seeking. 
Health behaviour theories of risk perception (Becker, 1974; Schwarzer, 
2008) focus on individual risks. Future research around genetic risks needs to 
explore ways to incorporate the family perspective into risk perception 
theories, to understand how, for example, perceptions of risks for children 
may contribute to preventive actions. Furthermore, research on illness 
representations needs to explore how representations of being ‘at risk’ for 
hereditary illnesses are integrated into illness representations, and whether 
these representations contribute to preventive actions. 
The qualitative results of this study showed that lay perspectives on 
receiving secondary findings from genome sequencing depend not only on the 
type of secondary findings but also on how counselling, surveillance and 
treatment for different conditions are organised. Practices of reporting genetic 
risks need to be carefully evaluated in contexts of different healthcare systems. 
When reporting genetic risks, attention should be paid not only to consent and 
reporting practices but also the practical paths through which people get 
access to counselling and relevant preventive treatment. This has implications 
for, among others, biobanks who report genetic risks back to biobank 
participants. Results of the current study show that it is not advisable to simply 
return risk information, but this needs to be combined with practical advice 
on where individuals may look for further reliable information, preventive 
treatment, and counselling for how to communicate this information within 
the family. Individuals should not be left on their own to make sense of genetic 
risk information without a possibility for expert support. Furthermore, it 
needs to be acknowledged that individual preferences and life situations may 
change in varied ways between the time of consent and the time when risks are 
reported to them. These lay perspectives need to be taken into account in 
guidelines, regulations and practices of reporting genetic risks.  
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 CONCLUSIONS 
Despite optimistic bias, risk perceptions of common diseases reflect actual risk 
factors such as family history, and behavioural and physiological risk factors. 
Family history contributes to perceived risk of diabetes, CVD, cancer, and 
depression independently of sociodemographics, health behaviour, body 
weight, and current depressive symptoms. Perceived risk of disease or 
biomarker feedback alone, however, are unlikely to predict health promoting 
changes in physical activity, body weight, or blood sugar. Interventions need 
to target risk perceptions together with other social cognitive factors, such as 
self-efficacy. This needs to be kept in mind when developing more and more 
individualized forms of risk feedback, such as polygenic risk score information 
concerning multifactorial diseases. 
Lay illness representations need to be taken into account in risk 
communication, as previous knowledge of diseases shapes how people process 
new risk information. When communicating genetic risks, it should be noted 
that lay people may not distinguish different types of diseases, for example 
heritable and multifactorial diseases, similarly as professionals do. This needs 
to be kept in mind also when formulating categories from which to choose 
from when consenting to secondary findings, to provide people with categories 
that they find useful and helpful for decision making. When reporting 
secondary findings from genome sequencing, people may expect timely access 
to counselling support and preventive treatment. In addition to formulating 
acceptable consent practices for receipt of secondary findings, preventive 
treatment paths for individuals and families need to be planned and 
communicated appropriately.  
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